Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:anilide
go back to main search page
Accession:CHEBI:13248 term browser browse the term
Definition:Any aromatic amide obtained by acylation of aniline.
Synonyms:related_synonym: Formula=C7H6NOR;   N-phenyl amide;   N-phenyl amides;   SMILES=[*]C(=O)Nc1ccccc1;   an anilide
 xref: KEGG:C01402;   PMID:23535982;   PMID:23968552;   PMID:24273122;   PMID:6205897


show annotations for term's descendants           Sort by:
 
3,3',4',5-tetrachlorosalicylanilide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atf3 activating transcription factor 3 increases expression ISO 3,3',4',5-tetrachlorosalicylanilide results in increased expression of ATF3 mRNA CTD PMID:27965148 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 increases expression ISO 3,3',4',5-tetrachlorosalicylanilide results in increased expression of DNAJB4 mRNA CTD PMID:27965148 NCBI chr 2:257,394,692...257,425,344
Ensembl chr 2:257,394,818...257,425,242
JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO 3,3',4',5-tetrachlorosalicylanilide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
JBrowse link
acetochlor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases activity
multiple interactions
ISO acetochlor results in increased activity of ABCB1 protein
ABCB1 protein affects the reaction [acetochlor results in increased susceptibility to Paclitaxel]
CTD PMID:18433974 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases export ISO ABCC1 protein results in increased export of acetochlor metabolite CTD PMID:18433974 NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
JBrowse link
G Aplf aprataxin and PNKP like factor affects response to substance ISO APLF gene SNP affects the susceptibility to acetochlor CTD PMID:25622337 NCBI chr 4:119,514,822...119,568,764
Ensembl chr 4:119,514,840...119,568,736
JBrowse link
G Bad BCL2-associated agonist of cell death increases expression ISO acetochlor results in increased expression of BAD protein CTD PMID:25291404 NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression ISO acetochlor results in increased expression of BAK1 protein CTD PMID:25291404 NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO acetochlor results in increased expression of BAX protein CTD PMID:25291404 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bcl2l1 Bcl2-like 1 affects expression ISO acetochlor affects the expression of BCL2L1 protein CTD PMID:25291404 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
JBrowse link
G Bid BH3 interacting domain death agonist increases expression ISO acetochlor results in increased expression of BID protein CTD PMID:25291404 NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased expression of CASP3 protein modified form] CTD PMID:25291404 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp9 caspase 9 multiple interactions
increases cleavage
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of CASP9 protein] CTD PMID:25291404 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases metabolic processing ISO CYP2B6 protein results in increased metabolism of acetochlor CTD PMID:11133395 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Gfral GDNF family receptor alpha like affects response to substance ISO GFRAL gene SNP affects the susceptibility to acetochlor CTD PMID:25622337 NCBI chr 8:83,235,647...83,282,635
Ensembl chr 8:83,236,103...83,280,888
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased phosphorylation of MAPK1 protein] CTD PMID:25291404 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
multiple interactions
ISO acetochlor results in increased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased phosphorylation of MAPK3 protein]
CTD PMID:25291404 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member affects expression ISO acetochlor affects the expression of MCL1 protein CTD PMID:25291404 NCBI chr 2:197,786,212...197,788,992 JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases cleavage
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of PARP1 protein] CTD PMID:25291404 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Rimklb ribosomal modification protein rimK-like family member B affects response to substance ISO RIMKLB gene SNP affects the susceptibility to acetochlor CTD PMID:25622337 NCBI chr 4:155,258,241...155,292,809
Ensembl chr 4:155,260,103...155,275,161
JBrowse link
G Thrb thyroid hormone receptor beta affects binding ISO acetochlor binds to THRB protein CTD PMID:28973306 NCBI chr15:8,890,578...9,239,815
Ensembl chr15:8,890,578...9,086,282
JBrowse link
alachlor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases activity
ISO ABCB1 protein affects the reaction [alachlor results in increased susceptibility to Paclitaxel]
alachlor results in increased activity of ABCB1 protein
CTD PMID:18433974 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Ache acetylcholinesterase increases activity
increases expression
ISO
EXP
alachlor results in increased activity of ACHE protein
alachlor results in increased expression of ACHE mRNA
CTD PMID:12419858, PMID:16998629 NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
JBrowse link
G Acsm4 acyl-CoA synthetase medium-chain family member 4 affects expression EXP alachlor affects the expression of ACSM4 mRNA CTD PMID:19425180 NCBI chr 1:189,432,604...189,458,799
Ensembl chr 1:189,432,604...189,457,048
JBrowse link
G Adarb1 adenosine deaminase, RNA-specific, B1 increases expression EXP alachlor results in increased expression of ADARB1 mRNA CTD PMID:12419858 NCBI chr20:11,972,352...12,101,022
Ensembl chr20:11,972,381...12,101,047
JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide affects expression EXP alachlor affects the expression of ADH7 mRNA CTD PMID:19425180 NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
JBrowse link
G Aen apoptosis enhancing nuclease affects expression EXP alachlor affects the expression of AEN mRNA CTD PMID:19425180 NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
JBrowse link
G Ago2 argonaute RISC catalytic component 2 increases expression EXP alachlor results in increased expression of AGO2 mRNA CTD PMID:12419858 NCBI chr 7:114,339,607...114,377,277
Ensembl chr 7:114,339,434...114,380,613
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of AKT1 protein; [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in decreased expression of AKT1 protein CTD PMID:19883720 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO alachlor inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
JBrowse link
G Apod apolipoprotein D affects expression EXP alachlor affects the expression of APOD mRNA CTD PMID:19425180 NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301
JBrowse link
G Ar androgen receptor multiple interactions ISO alachlor inhibits the reaction [Metribolone results in increased activity of AR protein]; Dihydrotestosterone inhibits the reaction [alachlor results in increased activity of AR protein] CTD PMID:15064155, PMID:18324785 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arhgap35 Rho GTPase activating protein 35 affects expression EXP alachlor affects the expression of ARHGAP35 mRNA CTD PMID:19425180 NCBI chr 1:78,456,409...78,573,374
Ensembl chr 1:78,456,409...78,573,374
JBrowse link
G Atic 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase increases expression EXP alachlor results in increased expression of ATIC mRNA CTD PMID:12419858 NCBI chr 9:78,862,013...78,882,061
Ensembl chr 9:78,862,013...78,882,060
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression EXP alachlor results in increased expression of BAX mRNA CTD PMID:12419858 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
multiple interactions
decreases response to substance
ISO alachlor results in increased expression of BCL2 protein
fulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein]; PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor]
CTD PMID:10545406, PMID:12730627 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bin1 bridging integrator 1 increases expression EXP alachlor results in increased expression of BIN1 mRNA CTD PMID:12419858 NCBI chr18:25,163,575...25,222,139
Ensembl chr18:25,163,561...25,222,135
JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression EXP alachlor results in increased expression of CALCA mRNA CTD PMID:12419858 NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
JBrowse link
G Car2 carbonic anhydrase 2 increases expression EXP alachlor results in increased expression of CA2 mRNA CTD PMID:12419858 NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
JBrowse link
G Ccnb1 cyclin B1 increases expression EXP alachlor results in increased expression of CCNB1 mRNA CTD PMID:12419858 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in increased expression of CCND1 protein CTD PMID:19883720 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccnd2 cyclin D2 increases expression EXP alachlor results in increased expression of CCND2 mRNA CTD PMID:12419858 NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
JBrowse link
G Cd200 Cd200 molecule increases expression EXP alachlor results in increased expression of CD200 mRNA CTD PMID:12419858 NCBI chr11:60,371,617...60,398,450
Ensembl chr11:60,371,684...60,403,196
JBrowse link
G Cdc123 cell division cycle 123 increases expression EXP alachlor results in increased expression of CDC123 mRNA CTD PMID:12419858 NCBI chr17:76,410,629...76,454,275
Ensembl chr17:76,410,585...76,454,282
JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression EXP alachlor results in increased expression of CDK1 mRNA CTD PMID:12419858 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Ces5a carboxylesterase 5A affects expression EXP alachlor affects the expression of CES5A mRNA CTD PMID:19425180 NCBI chr19:12,097,529...12,136,579
Ensembl chr19:12,097,632...12,136,240
JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression EXP alachlor results in increased expression of CGREF1 mRNA CTD PMID:12419858 NCBI chr 6:26,797,126...26,809,132
Ensembl chr 6:26,797,126...26,809,129
JBrowse link
G Clip2 CAP-GLY domain containing linker protein 2 increases expression EXP alachlor results in increased expression of CLIP2 mRNA CTD PMID:12419858 NCBI chr12:25,172,957...25,236,935
Ensembl chr12:25,173,005...25,237,009
JBrowse link
G Col11a1 collagen type XI alpha 1 chain increases expression EXP alachlor results in increased expression of COL11A1 mRNA CTD PMID:12419858 NCBI chr 2:216,863,423...217,056,523
Ensembl chr 2:216,863,428...217,056,523
JBrowse link
G Col5a1 collagen type V alpha 1 chain increases expression EXP alachlor results in increased expression of COL5A1 mRNA CTD PMID:12419858 NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
JBrowse link
G Col5a2 collagen type V alpha 2 chain increases expression EXP alachlor results in increased expression of COL5A2 mRNA CTD PMID:12419858 NCBI chr 9:52,091,088...52,238,735
Ensembl chr 9:52,092,511...52,238,564
JBrowse link
G Cplx2 complexin 2 increases expression EXP alachlor results in increased expression of CPLX2 mRNA CTD PMID:12419858 NCBI chr17:10,756,871...10,828,811
Ensembl chr17:10,756,285...10,818,835
JBrowse link
G Cpz carboxypeptidase Z increases expression EXP alachlor results in increased expression of CPZ mRNA CTD PMID:12419858 NCBI chr14:80,402,946...80,426,203
Ensembl chr14:80,403,001...80,426,245
JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression EXP alachlor results in increased expression of CRABP2 mRNA CTD PMID:12419858 NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 increases expression EXP alachlor results in increased expression of CXCR4 mRNA CTD PMID:12419858 NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression EXP alachlor results in increased expression of CYP1A1 protein CTD PMID:11850968 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression EXP alachlor results in increased expression of CYP1A2 protein CTD PMID:11850968 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 decreases expression EXP alachlor results in decreased expression of CYP2A3 protein CTD PMID:16698726 NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 multiple interactions EXP alachlor results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:11850968 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression EXP alachlor results in increased expression of CYP2B2 protein CTD PMID:11850968 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 decreases response to substance ISO CYP2B6 protein results in decreased susceptibility to alachlor CTD PMID:16277416 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression EXP alachlor results in increased expression of CYP3A23-3A1 mRNA CTD PMID:14613717 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Defa5 defensin alpha 5 increases expression EXP alachlor results in increased expression of DEFA5 mRNA CTD PMID:12419858 NCBI chr16:75,338,050...75,340,401
Ensembl chr16:75,338,052...75,340,360
JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression EXP alachlor results in increased expression of DMBT1 mRNA CTD PMID:12419858 NCBI chr 1:201,620,642...201,689,905
NCBI chr 1:203,149,414...203,228,705
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 increases expression EXP alachlor results in increased expression of EIF4EBP1 mRNA CTD PMID:12419858 NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
JBrowse link
G Eln elastin increases expression EXP alachlor results in increased expression of ELN mRNA CTD PMID:12419858 NCBI chr12:24,978,478...25,021,864
Ensembl chr12:24,978,483...25,021,863
JBrowse link
G Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 increases expression EXP alachlor results in increased expression of ENTPD2 mRNA CTD PMID:12419858 NCBI chr 3:2,617,795...2,623,818
Ensembl chr 3:2,617,805...2,623,445
JBrowse link
G Erp29 endoplasmic reticulum protein 29 increases expression EXP alachlor results in increased expression of ERP29 mRNA CTD PMID:12419858 NCBI chr12:40,619,377...40,625,884
Ensembl chr12:40,619,377...40,625,883
JBrowse link
G Esr1 estrogen receptor 1 affects binding
multiple interactions
ISO alachlor binds to ESR1 protein
[Dieldrin co-treated with alachlor] inhibits the reaction [Estradiol binds to ESR1 protein]; alachlor inhibits the reaction [Estradiol binds to ESR1 protein]
CTD PMID:9168004, PMID:14579009 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Fdps farnesyl diphosphate synthase increases expression EXP alachlor results in increased expression of FDPS mRNA CTD PMID:12419858 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fntb farnesyltransferase, CAAX box, beta increases expression EXP alachlor results in increased expression of FNTB mRNA CTD PMID:12419858 NCBI chr 6:99,883,959...99,966,988
Ensembl chr 6:99,883,959...99,966,988
JBrowse link
G Foxa2 forkhead box A2 increases expression EXP alachlor results in increased expression of FOXA2 mRNA CTD PMID:12419858 NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481
JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase increases expression EXP alachlor results in increased expression of FYN mRNA CTD PMID:12419858 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression EXP alachlor results in increased expression of GADD45A mRNA CTD PMID:12419858 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression EXP alachlor results in increased expression of GCLC protein CTD PMID:14563481 NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression EXP alachlor results in increased expression of GCLM protein CTD PMID:14563481 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
JBrowse link
G Gk glycerol kinase affects expression EXP alachlor affects the expression of GK mRNA CTD PMID:19425180 NCBI chr  X:54,227,291...54,303,897
Ensembl chr  X:54,227,397...54,303,864
JBrowse link
G Gng8 G protein subunit gamma 8 increases expression EXP alachlor results in increased expression of GNG8 mRNA CTD PMID:12419858 NCBI chr 1:78,818,360...78,822,224
Ensembl chr 1:78,818,404...78,822,224
JBrowse link
G Gpx6 glutathione peroxidase 6 increases expression EXP alachlor results in increased expression of GPX6 mRNA CTD PMID:12419858 NCBI chr17:45,439,268...45,446,952
Ensembl chr17:45,439,268...45,446,907
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein CTD PMID:19883720 NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
JBrowse link
G Hbb hemoglobin subunit beta affects binding EXP alachlor binds to HBB protein CTD PMID:10075819 NCBI chr 1:168,971,269...168,972,680
Ensembl chr 1:168,971,274...168,972,725
JBrowse link
G Hdc histidine decarboxylase increases expression EXP alachlor results in increased expression of HDC mRNA CTD PMID:12419858 NCBI chr 3:119,057,524...119,075,599
Ensembl chr 3:119,057,517...119,075,619
JBrowse link
G Hmgb2 high mobility group box 2 increases expression EXP alachlor results in increased expression of HMGB2 mRNA CTD PMID:12419858 NCBI chr16:36,077,615...36,080,191
Ensembl chr16:36,077,617...36,080,191
Ensembl chr11:36,077,617...36,080,191
JBrowse link
G Hmox1 heme oxygenase 1 increases expression EXP alachlor results in increased expression of HMOX1 mRNA CTD PMID:12419858 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 increases expression EXP alachlor results in increased expression of HNRNPA1 mRNA CTD PMID:12419858 NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
JBrowse link
G Homer2 homer scaffold protein 2 increases expression EXP alachlor results in increased expression of HOMER2 mRNA CTD PMID:12419858 NCBI chr 1:143,443,300...143,535,579
Ensembl chr 1:143,443,300...143,535,583
JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 increases expression EXP alachlor results in increased expression of HSP90AA1 mRNA alternative form CTD PMID:8792849 NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775
JBrowse link
G Ifnb1 interferon beta 1 multiple interactions ISO alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein] CTD PMID:15907790, PMID:18177342 NCBI chr 5:106,865,192...106,865,746
Ensembl chr 5:106,865,192...106,865,746
JBrowse link
G IgG-2a gamma-2a immunoglobulin heavy chain affects expression EXP alachlor affects the expression of IGG-2A mRNA CTD PMID:19425180
G Jchain joining chain of multimeric IgA and IgM affects expression EXP alachlor affects the expression of JCHAIN mRNA CTD PMID:19425180 NCBI chr14:21,176,841...21,183,731
Ensembl chr14:21,177,237...21,183,542
JBrowse link
G Kif3b kinesin family member 3B affects expression EXP alachlor affects the expression of KIF3B mRNA CTD PMID:19425180 NCBI chr 3:148,772,937...148,813,342
Ensembl chr 3:148,773,259...148,813,293
JBrowse link
G Klf6 Kruppel-like factor 6 increases expression EXP alachlor results in increased expression of KLF6 mRNA CTD PMID:12419858 NCBI chr17:67,887,939...67,945,052
Ensembl chr17:67,887,939...67,945,037
JBrowse link
G Lgals1 galectin 1 increases expression EXP alachlor results in increased expression of LGALS1 mRNA CTD PMID:12419858 NCBI chr 7:120,153,184...120,156,290
Ensembl chr 7:120,153,184...120,156,289
JBrowse link
G Lgi4 leucine-rich repeat LGI family, member 4 affects expression EXP alachlor affects the expression of LGI4 mRNA CTD PMID:19425180 NCBI chr 1:89,491,588...89,502,939
Ensembl chr 1:89,491,654...89,502,974
JBrowse link
G Lxn latexin increases expression EXP alachlor results in increased expression of LXN mRNA CTD PMID:12419858 NCBI chr 2:164,628,565...164,634,434
Ensembl chr 2:164,628,566...164,634,434
JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 increases expression EXP alachlor results in increased expression of MAP3K1 mRNA CTD PMID:12419858 NCBI chr 2:43,329,516...43,393,203
Ensembl chr 2:43,329,516...43,393,207
JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate increases expression EXP alachlor results in increased expression of MARCKS mRNA CTD PMID:12419858 NCBI chr20:42,966,140...42,971,838
Ensembl chr20:42,966,140...42,971,838
JBrowse link
G Mcm6 minichromosome maintenance complex component 6 increases expression EXP alachlor results in increased expression of MCM6 mRNA CTD PMID:12419858 NCBI chr13:45,042,882...45,068,073
Ensembl chr13:45,042,882...45,068,077
JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase increases expression EXP alachlor results in increased expression of MGAT2 mRNA CTD PMID:12419858 NCBI chr 6:91,476,698...91,479,187
Ensembl chr 6:91,476,698...91,479,183
JBrowse link
G Mmp2 matrix metallopeptidase 2 increases expression
increases activity
EXP alachlor results in increased expression of MMP2 mRNA
alachlor results in increased activity of MMP2 protein
CTD PMID:12419858, PMID:16178123 NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression EXP alachlor results in increased expression of MMP9 mRNA CTD PMID:12419858 NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
JBrowse link
G Moxd2 monooxygenase, DBH-like 2 affects expression EXP alachlor affects the expression of MOXD2 mRNA CTD PMID:19425180 NCBI chr 4:69,117,477...69,125,972
Ensembl chr 4:69,117,477...69,125,972
JBrowse link
G Mt3 metallothionein 3 increases expression EXP alachlor results in increased expression of MT3 mRNA CTD PMID:12419858 NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
JBrowse link
G Mvd mevalonate diphosphate decarboxylase increases expression EXP alachlor results in increased expression of MVD mRNA CTD PMID:12419858 NCBI chr19:55,258,910...55,268,933
Ensembl chr19:55,258,905...55,268,951
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in increased expression of MYC protein CTD PMID:19883720 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases activity ISO alachlor results in increased activity of NFE2L2 protein CTD PMID:20143881 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO alachlor inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; alachlor inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] CTD PMID:15907790, PMID:17015962 NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO alachlor inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] CTD PMID:15907790 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
JBrowse link
G Nfkbib NFKB inhibitor beta multiple interactions ISO alachlor inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIB protein] CTD PMID:15907790 NCBI chr 1:86,941,073...86,948,845
Ensembl chr 1:86,941,074...86,948,845
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] CTD PMID:15907790 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity
multiple interactions
ISO
EXP
alachlor results in increased activity of NR1I2 protein
alachlor binds to and results in increased activity of NR1I2 protein
CTD PMID:14613717, PMID:16565514, PMID:21115097 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO alachlor results in increased activity of NR1I3 protein CTD PMID:28927721 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 multiple interactions ISO alachlor inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; alachlor inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] CTD PMID:29149346 NCBI chr19:34,408,275...34,761,003
Ensembl chr19:34,448,289...34,752,695
JBrowse link
G Obp2a odorant binding protein 2A increases expression EXP alachlor results in increased expression of OBP2B mRNA CTD PMID:12419858 NCBI chr 3:2,908,684...2,913,362
Ensembl chr 3:2,910,083...2,913,362
JBrowse link
G Olr1144 olfactory receptor 1144 affects expression EXP alachlor affects the expression of OR7G2 mRNA CTD PMID:19425180 NCBI chr 8:19,332,109...19,333,047
Ensembl chr 8:19,332,109...19,333,047
JBrowse link
G Pcolce procollagen C-endopeptidase enhancer increases expression EXP alachlor results in increased expression of PCOLCE mRNA CTD PMID:12419858 NCBI chr12:22,153,995...22,160,311
Ensembl chr12:22,153,983...22,160,337
JBrowse link
G Pcsk6 proprotein convertase subtilisin/kexin type 6 increases expression EXP alachlor results in increased expression of PCSK6 mRNA CTD PMID:12419858 NCBI chr 1:126,749,508...126,947,392
Ensembl chr 1:126,749,508...126,947,392
JBrowse link
G Pdk2 pyruvate dehydrogenase kinase 2 increases expression EXP alachlor results in increased expression of PDK2 mRNA CTD PMID:12419858 NCBI chr10:82,838,270...82,852,758
Ensembl chr10:82,839,153...82,852,660
JBrowse link
G Pgr progesterone receptor multiple interactions
affects binding
ISO alachlor inhibits the reaction [Progesterone binds to PGR protein]
alachlor binds to PGR protein
CTD PMID:14579009 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
JBrowse link
G Phex phosphate regulating endopeptidase homolog, X-linked increases expression EXP alachlor results in increased expression of PHEX mRNA CTD PMID:12419858 NCBI chr  X:40,460,047...40,717,982
Ensembl chr  X:40,460,047...40,717,982
JBrowse link
G Plp1 proteolipid protein 1 affects expression EXP alachlor affects the expression of PLP1 mRNA CTD PMID:19425180 NCBI chr  X:107,494,326...107,511,355
Ensembl chr  X:107,496,072...107,511,348
JBrowse link
G Polr3g RNA polymerase III subunit G affects expression EXP alachlor affects the expression of POLR3G mRNA CTD PMID:19425180 NCBI chr 2:9,537,642...9,578,551
Ensembl chr 2:9,537,642...9,578,310
JBrowse link
G Prph peripherin increases expression EXP alachlor results in increased expression of PRPH mRNA CTD PMID:12419858 NCBI chr 7:140,742,406...140,746,197
Ensembl chr 7:140,742,418...140,746,197
JBrowse link
G Ptgds prostaglandin D2 synthase affects expression EXP alachlor affects the expression of PTGDS mRNA CTD PMID:19425180 NCBI chr 3:2,686,125...2,689,059
Ensembl chr 3:2,686,123...2,689,084
JBrowse link
G Ptgr1 prostaglandin reductase 1 increases expression EXP alachlor results in increased expression of PTGR1 mRNA CTD PMID:12419858 NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
JBrowse link
G Ptk2b protein tyrosine kinase 2 beta multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in decreased expression of PTK2B protein modified form CTD PMID:19883720 NCBI chr15:42,827,306...42,947,796
Ensembl chr15:42,827,310...42,947,656
JBrowse link
G Qdpr quinoid dihydropteridine reductase increases expression EXP alachlor results in increased expression of QDPR mRNA CTD PMID:12419858 NCBI chr14:70,164,682...70,178,284
Ensembl chr14:70,164,650...70,178,284
JBrowse link
G Qprt quinolinate phosphoribosyltransferase affects expression EXP alachlor affects the expression of QPRT mRNA CTD PMID:19425180 NCBI chr 1:198,544,262...198,559,556
Ensembl chr 1:198,544,262...198,559,568
JBrowse link
G Rassf8 Ras association domain family member 8 affects expression EXP alachlor affects the expression of RASSF8 mRNA CTD PMID:19425180 NCBI chr 4:180,059,020...180,135,924
Ensembl chr 4:180,062,799...180,135,966
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO alachlor inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] CTD PMID:15907790 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Rnf138 ring finger protein 138 affects expression EXP alachlor affects the expression of RNF138 mRNA CTD PMID:19425180 NCBI chr18:15,146,925...15,167,361 JBrowse link
G RT1-DMa RT1 class II, locus DMa increases expression EXP alachlor results in increased expression of HLA-DMA mRNA CTD PMID:12419858 NCBI chr20:3,935,512...3,938,915
Ensembl chr20:5,240,975...5,244,386
JBrowse link
G S100a8 S100 calcium binding protein A8 increases expression EXP alachlor results in increased expression of S100A8 mRNA CTD PMID:12419858 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G S100a9 S100 calcium binding protein A9 increases expression EXP alachlor results in increased expression of S100A9 mRNA CTD PMID:12419858 NCBI chr 2:190,097,436...190,100,209
Ensembl chr 2:190,097,554...190,100,276
JBrowse link
G Scrg1 stimulator of chondrogenesis 1 affects expression EXP alachlor affects the expression of SCRG1 mRNA CTD PMID:19425180 NCBI chr16:36,127,536...36,161,041
Ensembl chr16:36,125,904...36,161,089
JBrowse link
G Sec24c SEC24 homolog C, COPII coat complex component affects expression EXP alachlor affects the expression of SEC24C mRNA CTD PMID:19425180 NCBI chr15:4,035,196...4,057,209
Ensembl chr15:4,035,196...4,057,157
JBrowse link
G Serpinb11 serpin family B member 11 affects expression EXP alachlor affects the expression of SERPINB11 mRNA CTD PMID:19425180 NCBI chr13:27,217,385...27,257,181
Ensembl chr13:27,238,767...27,257,181
JBrowse link
G Serpinh1 serpin family H member 1 increases expression EXP alachlor results in increased expression of SERPINH1 mRNA CTD PMID:12419858 NCBI chr 1:164,301,010...164,308,306
Ensembl chr 1:164,301,010...164,308,317
JBrowse link
G Slc16a1 solute carrier family 16 member 1 increases expression EXP alachlor results in increased expression of SLC16A1 mRNA CTD PMID:12419858 NCBI chr 2:207,108,552...207,129,352
Ensembl chr 2:207,108,552...207,128,554
JBrowse link
G Slc22a20 solute carrier family 22 member 20 affects expression EXP alachlor affects the expression of SLC22A20 mRNA CTD PMID:19425180 NCBI chr 1:221,327,608...221,344,367
Ensembl chr 1:221,328,711...221,343,889
JBrowse link
G Slc25a35 solute carrier family 25, member 35 affects expression EXP alachlor affects the expression of SLC25A35 mRNA CTD PMID:19425180 NCBI chr10:55,554,911...55,559,083
Ensembl chr10:55,555,089...55,559,082
JBrowse link
G Slc4a2 solute carrier family 4 member 2 increases expression EXP alachlor results in increased expression of SLC4A2 mRNA CTD PMID:12419858 NCBI chr 4:7,264,677...7,282,355
Ensembl chr 4:7,264,683...7,281,223
JBrowse link
G Slc6a13 solute carrier family 6 member 13 affects expression EXP alachlor affects the expression of SLC6A13 mRNA CTD PMID:19425180 NCBI chr 4:153,874,942...153,912,185
Ensembl chr 4:153,874,852...153,912,155
JBrowse link
G Slc7a1 solute carrier family 7 member 1 increases expression EXP alachlor results in increased expression of SLC7A1 mRNA CTD PMID:12419858 NCBI chr12:8,032,775...8,108,972
Ensembl chr12:8,032,809...8,108,972
JBrowse link
G Snrpn small nuclear ribonucleoprotein polypeptide N affects expression EXP alachlor affects the expression of SNRPN mRNA CTD PMID:19425180 NCBI chr 1:195,074,328...195,096,460
Ensembl chr 1:195,074,330...195,096,460
JBrowse link
G Snurf SNRPN upstream reading frame affects expression EXP alachlor affects the expression of SNURF mRNA CTD PMID:19425180 NCBI chr 1:195,074,328...195,096,694
Ensembl chr 1:195,074,330...195,096,694
JBrowse link
G Sox11 SRY-box transcription factor 11 increases expression EXP alachlor results in increased expression of SOX11 mRNA CTD PMID:12419858 NCBI chr 6:46,629,967...46,631,988
Ensembl chr 6:46,629,974...46,631,983
JBrowse link
G Srpx sushi-repeat-containing protein, X-linked increases expression EXP alachlor results in increased expression of SRPX mRNA CTD PMID:12419858 NCBI chr  X:14,146,618...14,220,756
Ensembl chr  X:14,150,038...14,220,662
JBrowse link
G Tfrc transferrin receptor increases expression EXP alachlor results in increased expression of TFRC mRNA CTD PMID:12419858 NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression EXP alachlor results in increased expression of TIMP1 mRNA CTD PMID:12419858 NCBI chr  X:1,364,771...1,369,451
Ensembl chr  X:1,364,786...1,369,384
JBrowse link
G Tnc tenascin C increases expression EXP alachlor results in increased expression of TNC mRNA CTD PMID:12419858 NCBI chr 5:79,789,686...79,874,555
Ensembl chr 5:79,789,671...79,874,671
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO alachlor promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein] CTD PMID:15256756 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Top2a DNA topoisomerase II alpha increases expression EXP alachlor results in increased expression of TOP2A mRNA CTD PMID:12419858 NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
JBrowse link
G Tshb thyroid stimulating hormone subunit beta increases expression EXP alachlor results in increased expression of TSHB protein CTD PMID:8812207 NCBI chr 2:205,207,799...205,215,199
Ensembl chr 2:205,207,799...205,212,681
JBrowse link
Anilofos term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO Dihydrotestosterone inhibits the reaction [anilofos results in increased activity of AR protein] CTD PMID:15064155 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO anilofos binds to and results in increased activity of NR1I2 protein CTD PMID:21115097 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
JBrowse link
butachlor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor increases activity ISO butachlor results in increased activity of AR protein CTD PMID:20143881 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases metabolic processing ISO CYP2B6 protein results in increased metabolism of butachlor CTD PMID:11133395 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Dio1 iodothyronine deiodinase 1 decreases activity ISO butachlor results in decreased activity of DIO1 protein CTD PMID:29228274 NCBI chr 5:126,894,837...126,911,532
Ensembl chr 5:126,895,286...126,911,520
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 increases activity ISO butachlor results in increased activity of NR1H4 protein CTD PMID:20143881 NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases activity ISO butachlor results in increased activity of NR3C1 protein CTD PMID:20143881 NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
JBrowse link
G Thrb thyroid hormone receptor beta affects binding ISO butachlor binds to THRB protein CTD PMID:28973306 NCBI chr15:8,890,578...9,239,815
Ensembl chr15:8,890,578...9,086,282
JBrowse link
fentanyl term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases transport
multiple interactions
increases response to substance
ISO
EXP
ABCB1 protein results in increased transport of Fentanyl
tariquidar inhibits the reaction [ABCB1 protein results in increased transport of Fentanyl]
ABCB1 protein results in increased susceptibility to Fentanyl
CTD PMID:29669042 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Arrb2 arrestin, beta 2 affects localization ISO Fentanyl affects the localization of ARRB2 protein CTD PMID:27030709 NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
JBrowse link
G Calca calcitonin-related polypeptide alpha multiple interactions EXP Fentanyl inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Naloxone inhibits the reaction [Fentanyl inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]] CTD PMID:27030709 NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
JBrowse link
G Crh corticotropin releasing hormone affects expression EXP Fentanyl affects the expression of CRH mRNA CTD PMID:18819432 NCBI chr 2:104,459,999...104,461,863
Ensembl chr 2:104,459,999...104,461,863
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression EXP Fentanyl results in increased expression of FOS protein CTD PMID:7970238 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Gast gastrin multiple interactions EXP [fluanisone co-treated with Fentanyl co-treated with Midazolam] inhibits the reaction [GAST protein results in increased secretion of Histamine] CTD PMID:10864877 NCBI chr10:88,245,532...88,248,485
Ensembl chr10:88,245,532...88,248,484
JBrowse link
G Il2 interleukin 2 decreases expression ISO Fentanyl results in decreased expression of IL2 mRNA CTD PMID:23965172 NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
JBrowse link
G Il4 interleukin 4 increases expression ISO Fentanyl results in increased expression of IL4 mRNA CTD PMID:23965172 NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Fentanyl results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation ISO Fentanyl results in increased phosphorylation of MAPK1 protein CTD PMID:23965172 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation ISO Fentanyl results in increased phosphorylation of MAPK3 protein CTD PMID:23965172 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Nfkbia NFKB inhibitor alpha increases expression ISO Fentanyl results in increased expression of NFKBIA protein CTD PMID:22258905 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
JBrowse link
G Oprm1 opioid receptor, mu 1 increases phosphorylation ISO Fentanyl results in increased phosphorylation of OPRM1 protein CTD PMID:17240843, PMID:21957251, PMID:23300227 NCBI chr 1:43,454,803...43,704,948
Ensembl chr 1:43,454,803...43,704,948
JBrowse link
G Pdyn prodynorphin increases expression EXP Fentanyl results in increased expression of PDYN protein CTD PMID:19200067 NCBI chr 3:122,194,327...122,206,671
Ensembl chr 3:122,194,329...122,206,671
JBrowse link
G Pld2 phospholipase D2 increases activity ISO Fentanyl results in increased activity of PLD2 protein CTD PMID:23965172 NCBI chr10:57,161,921...57,181,148
Ensembl chr10:57,163,174...57,179,730
JBrowse link
G Pomc proopiomelanocortin decreases expression
multiple interactions
ISO Fentanyl results in decreased expression of POMC protein alternative form
[Fentanyl co-treated with Morphine] results in decreased expression of POMC protein alternative form
CTD PMID:20084599 NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
JBrowse link
G Ren renin multiple interactions ISO [Fentanyl co-treated with Isoflurane] results in decreased expression of REN protein CTD PMID:3284271 NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
JBrowse link
hydroxyflutamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions ISO hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAMTS1 mRNA]; hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAMTS1 protein] CTD PMID:17018655 NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
EXP hydroxyflutamide results in increased phosphorylation of AKT1 protein
hydroxyflutamide promotes the reaction [Testosterone results in increased phosphorylation of AKT1 protein]; wortmannin inhibits the reaction [hydroxyflutamide results in increased phosphorylation of AKT1 protein]
CTD PMID:26437446 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Ar androgen receptor decreases activity
decreases phosphorylation
increases response to substance
multiple interactions
affects activity
affects binding
ISO
EXP
hydroxyflutamide results in decreased activity of AR protein
hydroxyflutamide results in decreased phosphorylation of AR protein
AR protein mutant form results in increased susceptibility to hydroxyflutamide
[AR protein mutant form results in increased susceptibility to hydroxyflutamide] which results in increased activity of AR protein mutant form; hydroxyflutamide binds to and results in decreased activity of AR protein; hydroxyflutamide binds to and results in increased activity of AR protein; hydroxyflutamide binds to and results in increased activity of AR protein mutant form; hydroxyflutamide inhibits the reaction [[Dihydrotestosterone co-treated with Estradiol] results in decreased expression of AR mRNA]; hydroxyflutamide inhibits the reaction [[Dihydrotestosterone co-treated with Estradiol] results in decreased expression of AR protein]; hydroxyflutamide inhibits the reaction [Cadmium Chloride binds to AR protein]; hydroxyflutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR mRNA]; hydroxyflutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR protein]; hydroxyflutamide inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Estradiol results in decreased expression of AR protein]]; hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; hydroxyflutamide inhibits the reaction [Metribolone results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [Testosterone binds to and results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [Testosterone results in increased phosphorylation of AR protein]; OSM protein promotes the reaction [hydroxyflutamide binds to and results in increased activity of AR protein]
hydroxyflutamide affects the activity of AR protein
hydroxyflutamide inhibits the reaction [Metribolone binds to AR protein]
hydroxyflutamide analog binds to AR protein; hydroxyflutamide binds to AR protein
hydroxyflutamide binds to and results in decreased activity of AR protein; hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of AR mRNA]
CTD PMID:10053169, PMID:11751618, PMID:11861974, PMID:11861975, PMID:12114440, PMID:12730620, PMID:15056816, PMID:15084347, PMID:15994236, PMID:16934689, PMID:18275596, PMID:18324785, PMID:19672399, PMID:21295777, PMID:21506597, PMID:23146716, PMID:26485406, PMID:26602169, PMID:26778350, PMID:26867867, PMID:27473015, PMID:28009930, PMID:28163245, PMID:29392883, PMID:30247711, PMID:30582956 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Avp arginine vasopressin affects expression EXP hydroxyflutamide affects the expression of AVP mRNA CTD PMID:20810896 NCBI chr 3:123,117,482...123,119,460
Ensembl chr 3:123,117,492...123,119,460
JBrowse link
G Cdh1 cadherin 1 increases phosphorylation
multiple interactions
ISO hydroxyflutamide results in increased phosphorylation of CDH1 protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [hydroxyflutamide results in increased phosphorylation of CDH1 protein]
CTD PMID:28163245 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
JBrowse link
G Cdh2 cadherin 2 multiple interactions
decreases phosphorylation
ISO 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [hydroxyflutamide results in decreased phosphorylation of CDH2 protein]; wortmannin inhibits the reaction [hydroxyflutamide results in decreased phosphorylation of CDH2 protein] CTD PMID:28163245 NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
JBrowse link
G Ctnnb1 catenin beta 1 decreases phosphorylation
multiple interactions
ISO hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein]; wortmannin inhibits the reaction [hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein]
CTD PMID:28163245 NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression ISO hydroxyflutamide results in decreased expression of CYP11A1 mRNA CTD PMID:29556062 NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 increases expression ISO hydroxyflutamide results in increased expression of CYP17A1 mRNA CTD PMID:29556062 NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO hydroxyflutamide inhibits the reaction [[Dihydrotestosterone co-treated with Estradiol] results in decreased expression of ESR1 protein] CTD PMID:18275596 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions EXP [Testosterone co-treated with hydroxyflutamide] results in decreased expression of GJA1 protein; hydroxyflutamide results in decreased expression of and affects the localization of GJA1 protein; wortmannin inhibits the reaction [hydroxyflutamide results in decreased expression of GJA1 protein] CTD PMID:26437446 NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
JBrowse link
G Il6 interleukin 6 multiple interactions ISO hydroxyflutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [BCG Vaccine results in increased expression of IL6 mRNA]] CTD PMID:14532843 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 decreases expression ISO hydroxyflutamide results in decreased expression of LCP1 mRNA CTD PMID:29556062 NCBI chr15:57,170,566...57,277,811
Ensembl chr15:57,221,292...57,277,811
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
affects phosphorylation
increases phosphorylation
EXP
ISO
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [hydroxyflutamide results in increased phosphorylation of MAPK1 protein]; hydroxyflutamide promotes the reaction [Testosterone results in increased phosphorylation of MAPK1 protein]
hydroxyflutamide inhibits the reaction [Testosterone affects the phosphorylation of MAPK1 protein]
hydroxyflutamide affects the phosphorylation of MAPK1 protein
CTD PMID:26437446, PMID:28163245 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
affects phosphorylation
multiple interactions
EXP
ISO
hydroxyflutamide results in increased phosphorylation of MAPK3 protein
hydroxyflutamide affects the phosphorylation of MAPK3 protein
hydroxyflutamide inhibits the reaction [Testosterone affects the phosphorylation of MAPK3 protein]
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [hydroxyflutamide results in increased phosphorylation of MAPK3 protein]; hydroxyflutamide promotes the reaction [Testosterone results in increased phosphorylation of MAPK3 protein]
CTD PMID:26437446, PMID:28163245 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Msmb microseminoprotein, beta decreases expression ISO hydroxyflutamide results in decreased expression of MSMB mRNA CTD PMID:29556062 NCBI chr16:8,280,275...8,300,853
Ensembl chr16:8,280,275...8,300,852
JBrowse link
G Osm oncostatin M multiple interactions ISO OSM protein promotes the reaction [hydroxyflutamide binds to and results in increased activity of AR protein] CTD PMID:12114440 NCBI chr14:84,457,487...84,469,426
Ensembl chr14:84,465,515...84,470,409
JBrowse link
G Pip prolactin induced protein multiple interactions
decreases expression
ISO hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of PIP mRNA]
hydroxyflutamide results in decreased expression of PIP mRNA
CTD PMID:10402478 NCBI chr 4:71,320,859...71,325,153
Ensembl chr 4:71,320,859...71,325,153
JBrowse link
G Pten phosphatase and tensin homolog increases phosphorylation
multiple interactions
EXP hydroxyflutamide results in increased phosphorylation of PTEN protein
hydroxyflutamide promotes the reaction [Testosterone results in increased phosphorylation of PTEN protein]
CTD PMID:26437446 NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions
increases phosphorylation
ISO wortmannin promotes the reaction [hydroxyflutamide results in increased phosphorylation of RAF1 protein] CTD PMID:28163245 NCBI chr 4:147,532,040...147,592,769
Ensembl chr 4:147,532,042...147,592,699
JBrowse link
G Sf1 splicing factor 1 decreases expression ISO hydroxyflutamide results in decreased expression of SF1 mRNA CTD PMID:29556062 NCBI chr 1:221,735,512...221,749,216
Ensembl chr 1:221,735,517...221,749,086
JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase decreases phosphorylation
multiple interactions
EXP hydroxyflutamide results in decreased phosphorylation of SRC protein
hydroxyflutamide inhibits the reaction [Testosterone results in increased phosphorylation of SRC protein]
CTD PMID:26437446 NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 decreases expression ISO hydroxyflutamide results in decreased expression of SRD5A1 mRNA CTD PMID:29556062 NCBI chr 1:36,320,504...36,354,694
Ensembl chr 1:36,320,461...36,354,756
JBrowse link
G Srd5a2 steroid 5 alpha-reductase 2 multiple interactions ISO hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A2 mRNA] CTD PMID:15056816 NCBI chr 6:25,279,635...25,315,501
Ensembl chr 6:25,279,626...25,315,511
JBrowse link
phenacetin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aadac arylacetamide deacetylase increases hydrolysis ISO
EXP
AADAC protein results in increased hydrolysis of Phenacetin CTD PMID:22207054 NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480
JBrowse link
G Ahsp alpha hemoglobin stabilizing protein increases expression EXP Phenacetin results in increased expression of AHSP mRNA CTD PMID:17082564 NCBI chr 1:199,720,038...199,721,010
Ensembl chr 1:199,720,038...199,721,010
JBrowse link
G Akap10 A-kinase anchoring protein 10 increases expression EXP Phenacetin results in increased expression of AKAP10 mRNA CTD PMID:17082564 NCBI chr10:48,150,902...48,210,074
Ensembl chr10:48,150,902...48,210,074
JBrowse link
G Akr1b8 aldo-keto reductase family 1, member B8 increases expression EXP Phenacetin results in increased expression of AKR1B8 mRNA CTD PMID:17698508 NCBI chr 4:61,772,064...61,784,637
Ensembl chr 4:61,771,970...61,828,657
JBrowse link
G Alas2 5'-aminolevulinate synthase 2 increases expression EXP Phenacetin results in increased expression of ALAS2 mRNA CTD PMID:17082564 NCBI chr  X:23,167,576...23,187,356
Ensembl chr  X:23,167,696...23,187,341
JBrowse link
G Cd7 Cd7 molecule decreases expression EXP Phenacetin results in decreased expression of CD7 mRNA CTD PMID:17698508 NCBI chr10:110,229,931...110,232,812
Ensembl chr10:110,229,922...110,232,843
JBrowse link
G Cd8a CD8a molecule decreases expression EXP Phenacetin results in decreased expression of CD8A mRNA CTD PMID:17698508 NCBI chr 4:99,217,640...99,243,352
Ensembl chr 4:99,239,115...99,243,351
JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 increases expression EXP Phenacetin results in increased expression of CEACAM10 mRNA CTD PMID:17082564 NCBI chr 1:81,643,809...81,650,085
Ensembl chr 1:81,643,816...81,650,094
JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 increases expression EXP Phenacetin results in increased expression of CHCHD6 mRNA CTD PMID:17698508 NCBI chr 4:121,340,952...121,565,222
Ensembl chr 4:121,340,952...121,565,212
JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression EXP Phenacetin results in increased expression of CREG1 mRNA CTD PMID:17698508 NCBI chr13:83,972,186...83,984,675
Ensembl chr13:83,972,212...83,984,675
JBrowse link
G Ctsb cathepsin B increases expression EXP Phenacetin results in increased expression of CTSB mRNA CTD PMID:17698508 NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
JBrowse link
G Ctsd cathepsin D increases expression EXP Phenacetin results in increased expression of CTSD mRNA CTD PMID:17698508 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 affects metabolic processing
multiple interactions
increases metabolic processing
EXP
ISO
CYP1A1 protein affects the metabolism of Phenacetin
[CYP1A1 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen
CTD PMID:15231049, PMID:15879494, PMID:32198085 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases metabolic processing
increases oxidation
decreases ethylation
affects metabolic processing
increases expression
increases activity
ISO
EXP
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin]; 2-aminofluorene inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; 4-amino-2-phenoxymethanesulfonanilide promotes the reaction [CYP1A2 protein results in increased oxidation of Phenacetin]; 8-phenyltheophylline inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin]; [5-bromotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [5-chlorotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [5-fluoro-alpha-methyltryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [5-fluorotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [5-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [7-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [Amiodarone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen; [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [indopan analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [indopan results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [Methoxydimethyltryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [N,N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin; [Tryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; CYP1A2 protein results in increased oxidation of and results in decreased ethylation of Phenacetin; Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; O(6)-benzylguanine inhibits the reaction [CYP1A2 protein affects the metabolism of Phenacetin]; obeticholic acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]
CYP1A2 protein results in increased oxidation of Phenacetin; CYP1A2 protein results in increased oxidation of Phenacetin analog
[CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen; Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]
Phenacetin results in increased expression of CYP1A2 protein
[CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen; Phenacetin inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens]
Phenacetin results in increased activity of CYP1A2 protein
CTD PMID:1567206, PMID:3577206, PMID:8020169, PMID:8905919, PMID:9195021, PMID:10445756, PMID:10985777, PMID:11284709, PMID:11303964, PMID:11465391, PMID:11751525, PMID:11911841, PMID:12064368, PMID:12222751, PMID:12401345, PMID:12433797, PMID:12467917, PMID:14563787, PMID:14570767, PMID:14725854, PMID:15043991, PMID:15155557, PMID:15231049, PMID:15370959, PMID:15618748, PMID:15742976, PMID:15801540, PMID:15802386, PMID:15879494, PMID:16049126, PMID:16124035, PMID:17267297, PMID:17418993, PMID:17651725, PMID:17702393, PMID:18032064, PMID:19053182, PMID:19135037, PMID:21915887, PMID:22524704, PMID:23850985, PMID:26599973, PMID:27939613, PMID:28119166, PMID:28438436, PMID:28762043, PMID:29445054, PMID:30503582, PMID:31706005 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp2a2 cytochrome P450, family 2, subfamily a, polypeptide 2 affects metabolic processing EXP CYP2A2 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr 1:83,744,229...83,766,490
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 affects metabolic processing EXP CYP2C11 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
JBrowse link
G Cyp2c13 cytochrome P450, family 2, subfamily c, polypeptide 13 affects metabolic processing EXP CYP2C13 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr 1:258,796,624...258,877,023
Ensembl chr 1:258,796,622...258,877,045
JBrowse link
G Cyp2c22 cytochrome P450, family 2, subfamily c, polypeptide 22 decreases expression EXP Phenacetin results in decreased expression of CYP2C22 mRNA CTD PMID:17082564 NCBI chr 1:259,257,658...259,297,270
Ensembl chr 1:259,257,657...259,287,684
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 affects metabolic processing
decreases ethylation
EXP CYP2C6V1 protein affects the metabolism of Phenacetin
CYP2C6V1 protein results in decreased ethylation of Phenacetin
CTD PMID:11911841, PMID:15231049, PMID:15879494 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
JBrowse link
G Cyp2d1 cytochrome P450, family 2, subfamily d, polypeptide 1 affects metabolic processing EXP CYP2D1 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr 7:123,625,641...123,630,045
Ensembl chr 7:123,625,590...123,638,765
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects metabolic processing EXP CYP2E1 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 affects metabolic processing EXP CYP3A2 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 affects metabolic processing EXP CYP3A23-3A1 protein affects the metabolism of Phenacetin CTD PMID:15879494 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp46a1 cytochrome P450, family 46, subfamily a, polypeptide 1 decreases ethylation ISO CYP46A1 protein results in decreased ethylation of Phenacetin CTD PMID:14640697 NCBI chr 6:132,242,328...132,273,788
Ensembl chr 6:132,242,328...132,273,787
JBrowse link
G Emb embigin increases expression EXP Phenacetin results in increased expression of EMB mRNA CTD PMID:17082564 NCBI chr 2:49,682,763...49,733,475
Ensembl chr 2:49,682,754...49,732,253
JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression EXP Phenacetin results in increased expression of FABP4 mRNA CTD PMID:17698508 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
JBrowse link
G Fabp5 fatty acid binding protein 5 increases expression EXP Phenacetin results in increased expression of FABP5 mRNA CTD PMID:17698508 NCBI chr 2:93,981,662...93,985,322
Ensembl chr 2:93,981,656...93,985,378
JBrowse link
G Fcgr2b Fc fragment of IgG receptor IIb increases expression EXP Phenacetin results in increased expression of FCGR2B mRNA CTD PMID:17082564 NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815
JBrowse link
G Flg filaggrin increases expression EXP Phenacetin results in increased expression of FLG mRNA CTD PMID:17082564 NCBI chr 2:193,565,401...193,574,297 JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Phenacetin results in increased expression of FOSL1 mRNA CTD PMID:19000923 NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
JBrowse link
G Frem2 FRAS1 related extracellular matrix 2 decreases expression EXP Phenacetin results in decreased expression of FREM2 mRNA CTD PMID:17082564 NCBI chr 2:142,747,501...142,885,604
Ensembl chr 2:142,747,501...142,885,604
JBrowse link
G Ftl1 ferritin light chain 1 increases expression EXP Phenacetin results in increased expression of FTL1 mRNA CTD PMID:17698508 NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
JBrowse link
G G0s2 G0/G1switch 2 decreases expression EXP Phenacetin results in decreased expression of G0S2 mRNA CTD PMID:17082564 NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
JBrowse link
G Gcgr glucagon receptor increases expression EXP Phenacetin results in increased expression of GCGR mRNA CTD PMID:17698508 NCBI chr10:109,707,863...109,716,253
Ensembl chr10:109,707,962...109,716,128
JBrowse link
G Gfra1 GDNF family receptor alpha 1 increases expression EXP Phenacetin results in increased expression of GFRA1 mRNA CTD PMID:17698508 NCBI chr 1:279,203,046...279,572,789 JBrowse link
G Gpnmb glycoprotein nmb increases expression EXP Phenacetin results in increased expression of GPNMB mRNA CTD PMID:17082564, PMID:17698508 NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683
JBrowse link
G Gzmk granzyme K decreases expression EXP Phenacetin results in decreased expression of GZMK mRNA CTD PMID:17698508 NCBI chr 2:45,069,136...45,077,154
Ensembl chr 2:45,068,967...45,077,219
JBrowse link
G Hba-a1 hemoglobin alpha, adult chain 1 increases expression EXP Phenacetin results in increased expression of HBA-A1 mRNA CTD PMID:17082564 NCBI chr10:15,602,794...15,603,649
Ensembl chr10:15,602,794...15,603,649
JBrowse link
G Hbe2 hemoglobin, epsilon 2 increases expression EXP Phenacetin results in increased expression of HBE2 mRNA CTD PMID:17082564 NCBI chr 1:169,000,133...169,001,761
Ensembl chr 1:169,000,133...169,001,761
JBrowse link
G Hmox1 heme oxygenase 1 increases expression EXP Phenacetin results in increased expression of HMOX1 mRNA; Phenacetin results in increased expression of HMOX1 protein CTD PMID:17082564, PMID:17698508 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression EXP Phenacetin results in decreased expression of IGF1 mRNA CTD PMID:23142791 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 increases expression ISO Phenacetin results in increased expression of IL1RL1 mRNA CTD PMID:19000923 NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression EXP Phenacetin results in increased expression of LAMC2 mRNA CTD PMID:23142791 NCBI chr13:70,566,643...70,632,126
Ensembl chr13:70,566,643...70,626,252
JBrowse link
G Lbp lipopolysaccharide binding protein increases expression EXP Phenacetin results in increased expression of LBP mRNA CTD PMID:17082564 NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
JBrowse link
G Lgals3 galectin 3 increases expression EXP Phenacetin results in increased expression of LGALS3 mRNA CTD PMID:17082564, PMID:17698508 NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
JBrowse link
G Lgmn legumain increases expression EXP Phenacetin results in increased expression of LGMN mRNA CTD PMID:17698508 NCBI chr 6:126,282,246...126,308,207
Ensembl chr 6:126,282,233...126,320,726
JBrowse link
G Mt1 metallothionein 1 increases expression EXP Phenacetin results in increased expression of MT1A mRNA CTD PMID:17082564 NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
JBrowse link
G Nck2 NCK adaptor protein 2 decreases expression EXP Phenacetin results in decreased expression of NCK2 mRNA CTD PMID:17082564 NCBI chr 9:50,246,767...50,373,307
Ensembl chr 9:50,247,692...50,373,284
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases activity ISO Phenacetin results in increased activity of NFE2L2 protein CTD PMID:30203046 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Npy neuropeptide Y increases expression EXP Phenacetin results in increased expression of NPY mRNA CTD PMID:17082564 NCBI chr 4:79,557,856...79,565,059
Ensembl chr 4:79,557,854...79,565,097
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO Phenacetin results in increased activity of NR1I3 protein CTD PMID:30203046 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
JBrowse link
G Orc1 origin recognition complex, subunit 1 increases expression EXP Phenacetin results in increased expression of ORC1 mRNA CTD PMID:17698508 NCBI chr 5:128,186,651...128,212,901
Ensembl chr 5:128,190,708...128,210,445
JBrowse link
G Pepd peptidase D decreases activity ISO Phenacetin results in decreased activity of PEPD protein CTD PMID:16991207 NCBI chr 1:90,820,670...91,285,128 JBrowse link
G Plscr1 phospholipid scramblase 1 increases expression EXP Phenacetin results in increased expression of PLSCR1 mRNA CTD PMID:17082564 NCBI chr 8:99,625,523...99,645,882
Ensembl chr 8:99,625,545...99,725,217
JBrowse link
G Psmd6 proteasome 26S subunit, non-ATPase 6 increases expression EXP Phenacetin results in increased expression of PSMD6 mRNA CTD PMID:17082564 NCBI chr15:12,407,557...12,416,153
Ensembl chr15:12,407,524...12,416,105
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases activity ISO Phenacetin analog results in decreased activity of PTGS1 protein; Phenacetin results in decreased activity of PTGS1 protein CTD PMID:16141368 NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
JBrowse link
G Ptpmt1 protein tyrosine phosphatase, mitochondrial 1 increases expression EXP Phenacetin results in increased expression of PTPMT1 mRNA CTD PMID:17698508 NCBI chr 3:79,734,961...79,743,737
Ensembl chr 3:79,734,961...79,743,737
JBrowse link
G Rad51ap1 RAD51 associated protein 1 increases expression ISO Phenacetin results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 NCBI chr 4:159,469,803...159,482,869
Ensembl chr 4:159,469,804...159,482,869
JBrowse link
G RGD1306195 similar to RAN protein increases expression EXP Phenacetin results in increased expression of RGD1306195 mRNA CTD PMID:17698508 NCBI chr 5:54,480,783...54,482,159
Ensembl chr 5:54,480,787...54,482,159
JBrowse link
G Rhd Rh blood group, D antigen increases expression EXP Phenacetin results in increased expression of RHD mRNA CTD PMID:17082564 NCBI chr 5:153,197,416...153,232,009
Ensembl chr 5:153,197,459...153,232,687
JBrowse link
G Ripk3 receptor-interacting serine-threonine kinase 3 increases expression EXP Phenacetin results in increased expression of RIPK3 mRNA CTD PMID:17082564 NCBI chr15:34,470,796...34,479,741
Ensembl chr15:34,470,796...34,479,741
JBrowse link
G RT1-Bb RT1 class II, locus Bb decreases expression EXP Phenacetin results in decreased expression of RT1-BB mRNA CTD PMID:17698508 NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
JBrowse link
G S100a8 S100 calcium binding protein A8 increases expression EXP Phenacetin results in increased expression of S100A8 mRNA CTD PMID:17082564 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G S100a9 S100 calcium binding protein A9 increases expression EXP Phenacetin results in increased expression of S100A9 mRNA CTD PMID:17082564 NCBI chr 2:190,097,436...190,100,209
Ensembl chr 2:190,097,554...190,100,276
JBrowse link
G Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N increases expression EXP Phenacetin results in increased expression of SERPINA3N mRNA CTD PMID:17698508 NCBI chr 6:128,073,344...128,080,878
Ensembl chr 6:127,941,526...128,080,889
JBrowse link
G Slc22a25 solute carrier family 22, member 25 decreases activity ISO Phenacetin results in decreased activity of SLC22A9 protein CTD PMID:12388633 NCBI chr 1:224,596,886...224,698,512
Ensembl chr 1:224,596,887...224,698,514
JBrowse link
G Slc22a6 solute carrier family 22 member 6 decreases activity ISO Phenacetin results in decreased activity of SLC22A6 protein CTD PMID:12388633 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
JBrowse link
G Slc22a7 solute carrier family 22 member 7 decreases activity ISO Phenacetin results in decreased activity of SLC22A7 protein CTD PMID:12388633 NCBI chr 9:16,925,321...16,931,119
Ensembl chr 9:16,924,520...16,931,766
JBrowse link
G Slc39a14 solute carrier family 39 member 14 increases expression EXP Phenacetin results in increased expression of SLC39A14 mRNA CTD PMID:17082564 NCBI chr15:51,982,872...52,029,841
Ensembl chr15:51,982,982...52,029,816
JBrowse link
G Slc40a1 solute carrier family 40 member 1 increases expression EXP Phenacetin results in increased expression of SLC40A1 mRNA CTD PMID:17082564 NCBI chr 9:52,819,451...52,830,461
Ensembl chr 9:52,894,365...52,912,293
JBrowse link
G Spata48 spermatogenesis associated 48 increases expression EXP Phenacetin results in increased expression of SPATA48 mRNA CTD PMID:17698508 NCBI chr14:91,556,782...91,614,099
Ensembl chr14:91,557,601...91,613,540
JBrowse link
G Spink1 serine peptidase inhibitor, Kazal type 1 increases expression EXP Phenacetin results in increased expression of SPINK1 mRNA CTD PMID:17082564 NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
JBrowse link
G Tnfrsf17 TNF receptor superfamily member 17 decreases expression EXP Phenacetin results in decreased expression of TNFRSF17 mRNA CTD PMID:17698508 NCBI chr10:4,252,097...4,258,335
Ensembl chr10:4,251,941...4,257,868
JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression EXP Phenacetin results in increased expression of TRIB3 mRNA CTD PMID:17082564 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases response to substance EXP UGT1A1 gene mutant form results in increased susceptibility to Phenacetin CTD PMID:6776978 NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression EXP Phenacetin results in increased expression of VCAM1 mRNA CTD PMID:17082564 NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
JBrowse link
G Xpa XPA, DNA damage recognition and repair factor increases response to substance ISO XPA gene mutant form results in increased susceptibility to Phenacetin CTD PMID:16464479 NCBI chr 5:61,749,767...61,793,641
Ensembl chr 5:61,749,767...61,792,928
JBrowse link
G Zbtb44 zinc finger and BTB domain containing 44 decreases expression EXP Phenacetin results in decreased expression of ZBTB44 mRNA CTD PMID:17082564 NCBI chr 8:32,165,388...32,223,341
Ensembl chr 8:32,165,810...32,217,476
JBrowse link
Pretilachlor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity
multiple interactions
ISO pretilachlor results in increased activity of NR1I2 protein
pretilachlor binds to and results in increased activity of NR1I2 protein
CTD PMID:16565514, PMID:21115097, PMID:22223399 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
JBrowse link
propachlor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases activity ISO propachlor results in increased activity of CYP1A1 protein CTD PMID:10813365 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity ISO propachlor results in increased activity of CYP1A2 protein CTD PMID:10813365 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases activity EXP propachlor results in increased activity of CYP2B1 protein CTD PMID:10813365 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
propanil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor multiple interactions ISO Propanil binds to and results in increased activity of AHR protein CTD PMID:18835618 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ar androgen receptor affects binding
multiple interactions
EXP
ISO
Propanil binds to AR protein
Dihydrotestosterone inhibits the reaction [Propanil results in increased activity of AR protein]
CTD PMID:14565775, PMID:15064155 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression ISO Propanil results in increased expression of DNAJB1 mRNA CTD PMID:24356939 NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression ISO Propanil results in decreased expression of HMGCS1 mRNA CTD PMID:24356939 NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression ISO Propanil results in increased expression of HSPA1B mRNA CTD PMID:24356939 NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Propanil results in decreased expression of IDI1 mRNA CTD PMID:24356939 NCBI chr17:57,976,266...57,984,036
Ensembl chr17:57,976,268...57,984,036
JBrowse link
G Ifng interferon gamma multiple interactions ISO Lipopolysaccharides promotes the reaction [Propanil results in increased expression of IFNG mRNA]; Lipopolysaccharides promotes the reaction [Propanil results in increased expression of IFNG protein] CTD PMID:7679225 NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
JBrowse link
G Il2 interleukin 2 multiple interactions
decreases stability
ISO Propanil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Propanil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 protein]
Propanil results in decreased stability of IL2 mRNA
CTD PMID:9925799 NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
JBrowse link
G Il6 interleukin 6 multiple interactions
decreases secretion
ISO Propanil promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
Propanil results in decreased secretion of IL6 protein
CTD PMID:9201266, PMID:9221836, PMID:17585980 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO Propanil inhibits the reaction [[NFKB1 protein binds to NFKB1 protein] which binds to TNF promoter]; Propanil inhibits the reaction [[RELA protein binds to NFKB1 protein] which binds to TNF promoter] CTD PMID:11312646 NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] CTD PMID:17355946 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO Propanil inhibits the reaction [[RELA protein binds to NFKB1 protein] which binds to TNF promoter]; Propanil inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] CTD PMID:11312646 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Sqle squalene epoxidase decreases expression ISO Propanil results in decreased expression of SQLE mRNA CTD PMID:24356939 NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
JBrowse link
G Tnf tumor necrosis factor decreases expression
increases expression
decreases secretion
multiple interactions
ISO Propanil results in decreased expression of TNF protein
Propanil results in increased expression of TNF protein
Propanil results in decreased secretion of TNF protein
Lipopolysaccharides promotes the reaction [Propanil results in increased expression of TNF protein]; Propanil inhibits the reaction [[NFKB1 protein binds to NFKB1 protein] which binds to TNF promoter]; Propanil inhibits the reaction [[RELA protein binds to NFKB1 protein] which binds to TNF promoter]; Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD PMID:7679225, PMID:9201266, PMID:9221836, PMID:11312646, PMID:17355946 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Zfp628 zinc finger protein 628 decreases expression ISO Propanil results in decreased expression of ZNF628 mRNA CTD PMID:24356939 NCBI chr 1:72,465,403...72,474,442
Ensembl chr 1:72,465,341...72,468,738
JBrowse link
remifentanil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions
increases phosphorylation
EXP Ketamine inhibits the reaction [remifentanil results in increased phosphorylation of GRIN2B protein] CTD PMID:20042082 NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873
JBrowse link
G Htr3a 5-hydroxytryptamine receptor 3A affects activity ISO remifentanil affects the activity of HTR3A protein CTD PMID:18635474 NCBI chr 8:53,211,436...53,223,878
Ensembl chr 8:53,211,438...53,223,804
JBrowse link
G Prkcg protein kinase C, gamma multiple interactions
affects localization
EXP Lidocaine inhibits the reaction [remifentanil affects the localization of PRKCG protein] CTD PMID:19955894 NCBI chr 1:64,407,098...64,433,698
Ensembl chr 1:64,407,114...64,433,636
JBrowse link
sufentanil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Htr3a 5-hydroxytryptamine receptor 3A affects activity ISO Sufentanil affects the activity of HTR3A protein CTD PMID:18635474 NCBI chr 8:53,211,436...53,223,878
Ensembl chr 8:53,211,438...53,223,804
JBrowse link
G Pomc proopiomelanocortin decreases expression ISO Sufentanil results in decreased expression of POMC protein modified form CTD PMID:15714323 NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
JBrowse link
Suplatast tosilate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Tnf tumor necrosis factor multiple interactions ISO suplatast tosilate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] CTD PMID:17296442 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19816
    chemical entity 19816
      atom 19814
        nonmetal atom 19690
          nitrogen atom 18565
            nitrogen molecular entity 18565
              amide 17416
                aromatic amide 6685
                  anilide 266
                    (2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide 0
                    (2S,4S)-4-(4-bromophenyl)-2-(4-hydroxybutoxy)-N-phenyl-3,4-dihydro-2H-pyran-6-carboxamide 0
                    1-[(2,3-dimethyl-4-imidazolyl)methyl]-N-[4-(2-furanyl)phenyl]-3-piperidinecarboxamide 0
                    2,2,3,3-tetramethyl-N-[4-[4-[[oxo-(2,2,3,3-tetramethylcyclopropyl)methyl]amino]phenyl]sulfonylphenyl]-1-cyclopropanecarboxamide 0
                    2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide 0
                    2,3-dihydro-1,4-dioxin-5-carboxylic acid [2-(4-cyanoanilino)-2-oxoethyl] ester 0
                    2-(2,4-dichlorophenoxy)-N-[2-(methylthio)phenyl]acetamide 0
                    2-(2,4-dichlorophenoxy)-N-[4-(4-morpholinylmethyl)phenyl]acetamide 0
                    2-(2,4-dioxo-3-phenyl-5-thiazolidinyl)-N-(3-methylphenyl)acetamide 0
                    2-(2,4-dioxo-3-phenyl-5-thiazolidinyl)-N-phenylacetamide 0
                    2-(2,5-dimethylphenoxy)-N-(2-hydroxy-5-methylphenyl)acetamide 0
                    2-(2,6-dichlorophenyl)acetic acid [2-oxo-2-[4-(trifluoromethoxy)anilino]ethyl] ester 0
                    2-(2-hydroxyethylthio)-N-(2-methylphenyl)acetamide 0
                    2-(2-methylphenoxy)-N-[2-(methylthio)phenyl]acetamide 0
                    2-(3,5-dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid 0
                    2-(3,5-dimethylphenoxy)-N-[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide 0
                    2-(3-acetamidophenoxy)-N-phenylacetamide 0
                    2-(4,5,6,7-tetrahydroindazol-2-yl)-N-(2,4,6-trimethylphenyl)acetamide 0
                    2-(4,5-dihydro-1H-imidazol-2-ylthio)-N-(4-methylphenyl)acetamide 0
                    2-(4-Chloro-3,5-dimethylphenoxy)-N-(2-phenyl-2H-benzotriazol-5-yl)-acetamide 0
                    2-(4-bromophenoxy)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide 0
                    2-(4-methoxyphenoxy)-N-(2-methoxyphenyl)acetamide 0
                    2-METHYL-N-PHENYL-5,6-DIHYDRO-1,4-OXATHIINE-3-CARBOXAMIDE 0
                    2-[(2-anilino-2-oxoethyl)thio]butanedioic acid 0
                    2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-chlorophenyl)acetamide 0
                    2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(propylcarbamoylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methylphenyl)acetamide 0
                    2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-propan-2-ylphenyl)acetamide 0
                    2-[(2R,4aS,12aS)-8-[(2-methoxy-1-oxoethyl)amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(4-fluorophenyl)acetamide 0
                    2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                    2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide 0
                    2-[(4-cyano-1-methyl-5,6,7,8-tetrahydroisoquinolin-3-yl)thio]-N-(3-ethoxyphenyl)acetamide 0
                    2-[(5,6-dithiophen-2-yl-1,2,4-triazin-3-yl)oxy]-N-methyl-N-phenylacetamide 0
                    2-[2-[4-[4-(dimethylamino)phenyl]but-3-en-2-ylidene]hydrazinyl]-4-oxo-N-(4-propoxyphenyl)-5,6-dihydro-1,3-thiazine-6-carboxamide 0
                    2-[3-(2-furanylmethyl)-2-(4-methoxyphenyl)imino-4-oxo-5-thiazolidinyl]-N-(2-methoxyphenyl)acetamide 0
                    2-[3-cyano-4-(methoxymethyl)-6-methyl-2-oxo-1-pyridinyl]-N-(3,5-dimethylphenyl)acetamide 0
                    2-[4-[(carbamothioylhydrazinylidene)methyl]-2-methoxyphenoxy]-N-(3,4-dimethylphenyl)acetamide 0
                    2-[4-[[[ethylamino(sulfanylidene)methyl]hydrazinylidene]methyl]-2-methoxyphenoxy]-N-(4-methoxyphenyl)acetamide 0
                    2-[6-[(2-fluorophenyl)methyl]-5,7-dimethyl-4-oxo-3-pyrrolo[3,4-d]pyridazinyl]-N-(2,3,5,6-tetrafluorophenyl)acetamide 0
                    2-[[2-(3,4-dimethylanilino)-2-oxoethyl]thio]acetamide 0
                    2-[[4-(dimethylamino)phenyl]methylideneamino]oxy-N-(4-methylphenyl)acetamide 0
                    2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide 0
                    2-[[5-(2-furanyl)-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)acetamide 0
                    2-[[5-[3-(2,4-dichlorophenoxy)propyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-(2-ethyl-6-methylphenyl)acetamide 0
                    2-[[6-(2-furanyl)-3-pyridazinyl]thio]-N-(3-methylphenyl)acetamide 0
                    2-acetamido-4,5-dimethyl-3-thiophenecarboxylic acid [2-(2-chloro-5-methylsulfonylanilino)-2-oxoethyl] ester 0
                    2-amino-N-(4-ethylphenyl)-4-oxo-5,6-dihydro-1,3-thiazine-6-carboxamide 0
                    2-butenedioic acid bis[2-(3-chloro-4-methoxyanilino)-2-oxoethyl] ester 0
                    2-chloro-N-(2-chloro-5-methylsulfonylphenyl)acetamide 0
                    2-chloro-N-ethyl-N-phenylpropanamide 0
                    2-chloro-N-heptyl-N-(3-methylphenyl)acetamide 0
                    2-cyano-3-(2,5-dimethyl-1H-pyrrol-3-yl)-N-(2-fluorophenyl)-2-propenamide 0
                    2-cyano-3-[2,5-dimethyl-1-(3-pyridinyl)-3-pyrrolyl]-N-phenyl-2-propenamide 0
                    2-cyano-3-oxo-N-[4-(trifluoromethoxy)phenyl]butanamide 0
                    2-cyano-N-(2,4-dimethylphenyl)-3-(3-thiophenyl)-2-propenamide 0
                    2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide 0
                    2-cyano-N-(2,5-dibromophenyl)-3-oxobutanamide 0
                    2-methylpropanethioic acid S-[2-[[[1-(2-ethylbutyl)cyclohexyl]-oxomethyl]amino]phenyl] ester 0
                    2-phenylbutanoic acid [2-(3,5-dichloroanilino)-2-oxoethyl] ester 0
                    3-(2-chloro-6-fluorophenyl)-N-(2-hydroxy-5-methylphenyl)-4,5-dihydroisoxazole-5-carboxamide 0
                    3-(5-cinnamylidene-2,4-dioxo-3-thiazolidinyl)-N-(4-hydroxyphenyl)propanamide 0
                    3-(carbamothioylhydrazinylidene)-N-(3,4-dichlorophenyl)butanamide 0
                    3-Oxo-N-phenyl-N-(phenylmethyl)butanamide 0
                    3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid 0
                    3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluoro-4-methylphenyl)propanamide 0
                    3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluorophenyl)propanamide 0
                    3-[[4-(dimethylamino)phenyl]methylidene]-2-(4-morpholinyl)-N-(3,4,5-trimethoxyphenyl)-1-cyclohexenecarboxamide 0
                    3-hydroxy-1-adamantanecarboxylic acid [2-[2-(difluoromethoxy)anilino]-2-oxoethyl] ester 0
                    3-methylthiofentanyl + 0
                    4-(3-fluoroanilino)-4-oxobutanoic acid 0
                    4-(3-methylanilino)-4-oxobutanoic acid 0
                    4-(4-acetamidophenyl)-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester 0
                    4-(4-chloro-2-methylphenoxy)-N-[3-(methylthio)phenyl]butanamide 0
                    4-[3-[2-(4-cyclobutyl-2-thiazolyl)ethenyl]anilino]-2,2-diethyl-4-oxobutanoic acid 0
                    4-[5-(4-ethoxyphenyl)-3-isoxazolyl]-N-(3-methoxyphenyl)butanamide 0
                    4-[[(2,4-difluoroanilino)-sulfanylidenemethyl]hydrazo]-N-(3,4-dimethylphenyl)-4-oxobutanamide 0
                    4-[[4-ethyl-5-[(2-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)-3-oxobutanamide 0
                    4-amino-1,2,5-oxadiazole-3-carboxylic acid [2-(2,6-dimethylanilino)-2-oxoethyl] ester 0
                    4-anilino-4-oxobutanoic acid (4-tert-butylcyclohexyl) ester 0
                    4-chloro-2-methyl-N-[1-[3-[(1-oxo-2-phenoxyethyl)amino]phenyl]ethylideneamino]-3-pyrazolecarboxamide 0
                    5-acetylamido-2-chloroaniline 0
                    5-amino-1-[2-(2-ethoxyanilino)-2-oxoethyl]-N-(2-furanylmethyl)-4-triazolecarboxamide 0
                    5-cyano-6-[[2-(2,3-dimethylanilino)-2-oxoethyl]thio]-4-(2-furanyl)-2-methyl-N-phenyl-1,4-dihydropyridine-3-carboxamide 0
                    6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid 0
                    6-[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-5-thieno[2,3-b]pyrrolecarboxylic acid methyl ester 0
                    6-methyl-N-(2-methylphenyl)-2-oxo-4-phenyl-3,4-dihydro-1H-pyrimidine-5-carboxamide 0
                    7-[(3-fluoro-6-oxo-1-cyclohexa-2,4-dienylidene)methylhydrazo]-N-(2-hydroxyphenyl)-7-oxoheptanamide 0
                    Actarit 0
                    Anilofos 2
                    Butenachlor 0
                    CID 3191469 0
                    CID 3198732 0
                    Chloranocryl 0
                    Clomeprop 0
                    Cypromid 0
                    Delachlor 0
                    Fosmethilan 0
                    LSM-36717 0
                    M2 0
                    Metsulfovax 0
                    Monalide 0
                    N'-(2-propoxyphenyl)-2-butenediamide 0
                    N'-(cinnamylideneamino)-N-(2-hydroxyphenyl)octanediamide 0
                    N'-[(2,3-diethoxyphenyl)methylideneamino]-N-(2-hydroxyphenyl)octanediamide 0
                    N'-[[4-(2-hydroxyethoxy)phenyl]methylideneamino]-N-(2-hydroxyphenyl)octanediamide 0
                    N(5)-phenyl-L-glutamine 0
                    N-(2,4-dichlorophenyl)-2-[[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                    N-(2,4-difluorophenyl)-2-[2-methylimino-4-oxo-3-[(4-prop-2-enoxyphenyl)methylideneamino]-5-thiazolidinyl]acetamide 0
                    N-(2,4-dimethylphenyl)-N'-(2-furanylmethylideneamino)butanediamide 0
                    N-(2,4-dimethylphenyl)-N'-[(5-methyl-2-furanyl)methylideneamino]butanediamide 0
                    N-(2,5-difluorophenyl)-2-oxolanecarboxamide 0
                    N-(2-chlorophenyl)-2-[[5-[5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                    N-(2-ethoxyphenyl)-2-(4-methoxyphenoxy)propanamide 0
                    N-(2-ethyl-6-methylphenyl)-2-(4-methyl-1-oxo-2-pyrrolo[1,2-d][1,2,4]triazinyl)acetamide 0
                    N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide 0
                    N-(2-fluorophenyl)-2-(3-methoxyphenyl)imino-3-methyl-4-oxo-1,3-thiazinane-6-carboxamide 0
                    N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide 0
                    N-(2-fluorophenyl)-3-phenylpropanamide 0
                    N-(2-hydroxyphenyl)-7-[3-(3-methoxy-4-oxo-1-cyclohexa-2,5-dienylidene)prop-1-enylhydrazo]-7-oxoheptanamide 0
                    N-(2-hydroxyphenyl)-N'-[(5-nitro-2-thiophenyl)methylideneamino]octanediamide 0
                    N-(2-methoxy-5-methylphenyl)-2-[[1-(phenylmethyl)-5-tetrazolyl]thio]acetamide 0
                    N-(2-methoxy-5-methylphenyl)-3-(4-methoxyphenyl)sulfonylpropanamide 0
                    N-(2-methoxyphenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide 0
                    N-(2-methoxyphenyl)-3-[[2-(4-oxo-1-cyclohexa-2,5-dienylidene)-3H-1,3,4-oxadiazol-5-yl]thio]propanamide 0
                    N-(2-methoxyphenyl)-N-[(3-oxo-1-benzothiophen-2-ylidene)amino]acetamide 0
                    N-(3,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxyiminomethyl]-3-(dimethylamino)-2-propenamide 0
                    N-(3,4-dimethylphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide 0
                    N-(3,4-dimethylphenyl)-2-[[5-[3-(4-methoxyphenyl)propyl]-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                    N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide 0
                    N-(3,4-dimethylphenyl)-N'-[(5-nitro-2-furanyl)methylideneamino]butanediamide 0
                    N-(3,5-Dichlorophenyl)-2-[4-(2-phenyl-1,3-thiazol-4-yl)pyrimidin-2-yl]sulfanylacetamide 0
                    N-(3,5-dichlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide 0
                    N-(3,5-dimethylphenyl)-3-(5-nitro-2-thiophenyl)-2-propenamide 0
                    N-(3-Benzooxazol-2-yl-4-hydroxy-phenyl)-2-p-tolyloxyacetamide 0
                    N-(3-chloro-4-methylphenyl)-2-(2-formylphenoxy)acetamide 0
                    N-(3-chloro-4-methylphenyl)-2-[3-(5-methyl-2-tetrazolyl)-1-adamantyl]acetamide 0
                    N-(3-chlorophenyl)-2-[4-oxo-2-phenylimino-3-(2-pyridinylmethyl)-5-thiazolidinyl]acetamide 0
                    N-(3-chlorophenyl)-2-[[2-(2-pyridinyl)-2,3-dihydro-1,3,4-thiadiazol-5-yl]thio]acetamide 0
                    N-(3-chlorophenyl)-2-[[2-(4-chlorophenyl)-6-oxo-1H-1,3,5-triazin-4-yl]thio]acetamide 0
                    N-(3-chlorophenyl)-2-[[5-[5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                    N-(3-chlorophenyl)-2-cyano-3-(3-pyridinyl)-2-propenamide 0
                    N-(3-ethylphenyl)-2-phenoxyacetamide 0
                    N-(3-fluoro-4-methylphenyl)-1-(2-pyrimidinyl)-3-piperidinecarboxamide 0
                    N-(3-hydroxyphenyl)-2-(2,4,5-trichlorophenoxy)acetamide 0
                    N-(3-methoxyphenyl)-2-(2-pyridinylthio)acetamide 0
                    N-(3-methoxyphenyl)-3-[(4-methylphenyl)thio]propanamide 0
                    N-(3-methoxyphenyl)-5-oxo-6,7-dihydro-[1,2,4]triazolo[3,4-b][1,3]thiazine-7-carboxamide 0
                    N-(3-methylphenyl)-2-[4-[2-(5-nitro-2,4-dioxo-1H-pyrimidin-6-yl)ethenyl]phenoxy]acetamide 0
                    N-(4-acetamidophenyl)-2-(5-methyl-4,5,6,7-tetrahydroindazol-2-yl)acetamide 0
                    N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide 0
                    N-(4-acetamidophenyl)-2-[5-(1-piperidinylsulfonyl)-2-thiophenyl]acetamide 0
                    N-(4-anilinophenyl)-2,2,2-trichloroacetamide 0
                    N-(4-anilinophenyl)-2-methylpropanamide 0
                    N-(4-anilinophenyl)cyclopropanecarboxamide 0
                    N-(4-bromo-2-fluorophenyl)-1-methylsulfonyl-4-piperidinecarboxamide 0
                    N-(4-bromo-3-chlorophenyl)-5-oxo-1-propan-2-yl-3-pyrrolidinecarboxamide 0
                    N-(4-bromophenyl)-4-[(3-nitro-6-oxo-1-cyclohexa-2,4-dienylidene)methylhydrazo]-4-oxobutanamide 0
                    N-(4-chloro-3-methylphenyl)-2-phenoxyacetamide 0
                    N-(4-chlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide 0
                    N-(4-chlorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide 0
                    N-(4-cyclohexylphenyl)-2-(2-hydroxyethylthio)acetamide 0
                    N-(4-ethylphenyl)-3-(1-pyrrolyl)propanamide 0
                    N-(4-ethylphenyl)-9-bicyclo[6.1.0]non-6-enecarboxamide 0
                    N-(4-fluorophenyl)-2-(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)-2-oxoacetamide 0
                    N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide 0
                    N-(4-fluorophenyl)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-[(4-methoxyphenyl)methyl]acetamide 0
                    N-(4-fluorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide 0
                    N-(4-fluorophenyl)-N'-hydroxyoctanediamide 0
                    N-(4-hydroxyphenyl)-4-[5-[(4-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-3-thiazolidinyl]butanamide 0
                    N-(4-hydroxyphenyl)eicosa-5,8,11,14-tetraenamide 0
                    N-(4-methoxyphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide 0
                    N-(4-methoxyphenyl)-5-oxo-6,7-dihydro-[1,2,4]triazolo[3,4-b][1,3]thiazine-7-carboxamide 0
                    N-(4-methoxyphenyl)-9-bicyclo[6.1.0]non-4-enecarboxamide 0
                    N-(4-methylphenyl)-2-(3-oxo-5,6-dihydroimidazo[2,1-b]thiazol-2-yl)acetamide 0
                    N-(4-methylphenyl)-2-[[(4-methylphenyl)-oxomethyl]hydrazo]-4-oxo-5,6-dihydro-1,3-thiazine-6-carboxamide 0
                    N-(4-methylphenyl)-4-oxo-4-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methylhydrazo]butanamide 0
                    N-[(2R,4aR,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                    N-[(2R,4aR,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                    N-[(2R,4aS,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide 0
                    N-[(2R,4aS,12aS)-2-[2-(2,6-difluoroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]propanamide 0
                    N-[(2R,4aS,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                    N-[(2R,4aS,12aS)-2-[2-(4-chloroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methylpropanamide 0
                    N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-methylanilino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]cyclobutanecarboxamide 0
                    N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(4-propan-2-ylanilino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-isoxazolecarboxamide 0
                    N-[(2S,4aR,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                    N-[(2S,4aR,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide 0
                    N-[(2S,4aS,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide 0
                    N-[(2S,4aS,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                    N-[(4-acetamidophenyl)methylideneamino]-2-cyclohexylacetamide 0
                    N-[1-(3-acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide 0
                    N-[1-(4-acetamidophenyl)ethylideneamino]cyclopentanecarboxamide 0
                    N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide 0
                    N-[1-[4-[(2,2,2-trifluoro-1-oxoethyl)amino]phenyl]ethylideneamino]cyclopentanecarboxamide 0
                    N-[1-[4-[(2,2,2-trifluoro-1-oxoethyl)amino]phenyl]ethylideneamino]pentanamide 0
                    N-[2-[1-(3,5-dimethyl-1-piperidinyl)-1-oxopropan-2-yl]oxyphenyl]acetamide 0
                    N-[2-[3-(ethylthio)-5-oxo-2H-1,2,4-triazin-6-yl]phenyl]propanamide 0
                    N-[2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenyl]acetamide 0
                    N-[3-(2-phenyl-4-thiazolyl)phenyl]propanamide 0
                    N-[3-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide 0
                    N-[3-[[(3S,3'S,4'R,5'S)-5'-(2-hydroxyethyl)-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-2-oxo-1-spiro[indole-3,2'-oxolane]yl]methyl]phenyl]acetamide 0
                    N-[4-(1-azepanyl)phenyl]-2-chloroacetamide 0
                    N-[4-(4-morpholinylazo)phenyl]acetamide 0
                    N-[4-(benzenesulfonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide 0
                    N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide 0
                    N-[4-(dimethylamino)phenyl]-3-(5-methyl-2-furanyl)-2-propenamide 0
                    N-[4-[(2-furanylmethylamino)-sulfanylidenemethyl]phenyl]acetamide 0
                    N-[4-[(8-ethoxy-4,4-dimethyl-5H-dithiolo[3,4-c]quinolin-1-ylidene)amino]phenyl]acetamide 0
                    N-[4-[1-(acetylhydrazinylidene)ethyl]phenyl]cyclopropanecarboxamide 0
                    N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide 0
                    N-[4-[2-(2-oxolanylmethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide 0
                    N-[4-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide 0
                    N-[4-[2-[(6-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide 0
                    N-[4-[2-[2-(1-phenylethylidene)hydrazinyl]-4-thiazolyl]phenyl]acetamide 0
                    N-[4-[2-[2-(pyridin-4-ylmethylidene)hydrazinyl]-4-thiazolyl]phenyl]butanamide 0
                    N-[4-[2-[5-(6-oxo-1-cyclohexa-2,4-dienylidene)-2H-1,2,4-oxadiazol-3-yl]ethenyl]phenyl]acetamide 0
                    N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-phenoxybutanamide 0
                    N-[4-[6-amino-5-cyano-4-(3-ethoxy-4-oxo-1-cyclohexa-2,5-dienylidene)-1H-pyridin-2-yl]phenyl]acetamide 0
                    N-[4-[[1-(2-furanylmethyl)-2,4,6-trioxo-1,3-diazinan-5-ylidene]methylamino]phenyl]acetamide 0
                    N-[4-[[1-[2-(3,4-dimethoxyphenyl)ethyl]-2,4,6-trioxo-1,3-diazinan-5-ylidene]methylamino]phenyl]acetamide 0
                    N-[4-[[2-(4-acetamidoanilino)-5-nitro-4-pyrimidinyl]amino]phenyl]acetamide 0
                    N-[4-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]phenyl]acetamide 0
                    N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-3-methoxybenzamide 0
                    N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-5-bromo-2-furancarboxamide 0
                    N-[[4-(2,3-dichloroanilino)-4-oxobutan-2-ylidene]amino]-2-methylbenzamide 0
                    N-[[4-oxo-4-(2,4,6-trimethylanilino)butan-2-ylidene]amino]carbamic acid tert-butyl ester 0
                    N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide 0
                    N-cyano-N'-propan-2-ylcarbamimidothioic acid [2-(2-methoxyanilino)-2-oxoethyl] ester 0
                    N-phenyl-9-bicyclo[6.1.0]non-6-enecarboxamide 0
                    N-phenyl-N'-(pyridin-4-ylmethylideneamino)butanediamide 0
                    N-phenylacetamide + 221
                    Pentanochlor 0
                    Pretilachlor 1
                    Prinomide 0
                    Pyracarbolid 0
                    Sufentanil citrate 0
                    Suplatast tosilate 1
                    Thenylchlor 0
                    U100313 0
                    YC 170 0
                    acedapsone 0
                    acetarsol 0
                    arsthinol 0
                    benodanil 0
                    butacetin 0
                    carbamothioic acid S-[2-(2-methoxyanilino)-2-oxoethyl] ester 0
                    carboxin 0
                    cyclanilide 0
                    diampromide 0
                    fenfuram 0
                    fenoxedil 0
                    fentanyl + 17
                    glycobiarsol 0
                    hydroxyflutamide 24
                    iomeglamic acid 0
                    linolenic acid anilide 0
                    linoleylanilide 0
                    methfuroxam 0
                    monoacetyldapsone 0
                    norfentanyl 0
                    o-Chloroacetanilide 0
                    oleylanilide 0
                    oxycarboxin 0
                    p-Chloroacetoacetanilide 0
                    p-Lactophenetide 0
                    propachlor 3
                    propachlor ESA 0
                    propachlor OXA 0
                    propanil 15
                    remifentanil + 3
                    salicylanilides + 3
                    succisulfone 0
                    sufentanil 2
                    thienylfentanyl 0
                    thioacetazone 0
                    thiocyanic acid [4-[(2-chloro-1-oxoethyl)amino]-3,5-dimethylphenyl] ester 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19816
    subatomic particle 19814
      composite particle 19814
        hadron 19814
          baryon 19814
            nucleon 19814
              atomic nucleus 19814
                atom 19814
                  main group element atom 19702
                    main group molecular entity 19702
                      s-block molecular entity 19461
                        hydrogen molecular entity 19452
                          hydrides 18707
                            inorganic hydride 17430
                              pnictogen hydride 17402
                                nitrogen hydride 17243
                                  azane 16960
                                    ammonia 16959
                                      organic amino compound 16958
                                        primary amino compound 7872
                                          primary amine 5674
                                            primary arylamine 2956
                                              aniline 2804
                                                anilide 266
                                                  (2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide 0
                                                  (2S,4S)-4-(4-bromophenyl)-2-(4-hydroxybutoxy)-N-phenyl-3,4-dihydro-2H-pyran-6-carboxamide 0
                                                  1-[(2,3-dimethyl-4-imidazolyl)methyl]-N-[4-(2-furanyl)phenyl]-3-piperidinecarboxamide 0
                                                  2,2,3,3-tetramethyl-N-[4-[4-[[oxo-(2,2,3,3-tetramethylcyclopropyl)methyl]amino]phenyl]sulfonylphenyl]-1-cyclopropanecarboxamide 0
                                                  2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide 0
                                                  2,3-dihydro-1,4-dioxin-5-carboxylic acid [2-(4-cyanoanilino)-2-oxoethyl] ester 0
                                                  2-(2,4-dichlorophenoxy)-N-[2-(methylthio)phenyl]acetamide 0
                                                  2-(2,4-dichlorophenoxy)-N-[4-(4-morpholinylmethyl)phenyl]acetamide 0
                                                  2-(2,4-dioxo-3-phenyl-5-thiazolidinyl)-N-(3-methylphenyl)acetamide 0
                                                  2-(2,4-dioxo-3-phenyl-5-thiazolidinyl)-N-phenylacetamide 0
                                                  2-(2,5-dimethylphenoxy)-N-(2-hydroxy-5-methylphenyl)acetamide 0
                                                  2-(2,6-dichlorophenyl)acetic acid [2-oxo-2-[4-(trifluoromethoxy)anilino]ethyl] ester 0
                                                  2-(2-hydroxyethylthio)-N-(2-methylphenyl)acetamide 0
                                                  2-(2-methylphenoxy)-N-[2-(methylthio)phenyl]acetamide 0
                                                  2-(3,5-dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid 0
                                                  2-(3,5-dimethylphenoxy)-N-[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide 0
                                                  2-(3-acetamidophenoxy)-N-phenylacetamide 0
                                                  2-(4,5,6,7-tetrahydroindazol-2-yl)-N-(2,4,6-trimethylphenyl)acetamide 0
                                                  2-(4,5-dihydro-1H-imidazol-2-ylthio)-N-(4-methylphenyl)acetamide 0
                                                  2-(4-Chloro-3,5-dimethylphenoxy)-N-(2-phenyl-2H-benzotriazol-5-yl)-acetamide 0
                                                  2-(4-bromophenoxy)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide 0
                                                  2-(4-methoxyphenoxy)-N-(2-methoxyphenyl)acetamide 0
                                                  2-METHYL-N-PHENYL-5,6-DIHYDRO-1,4-OXATHIINE-3-CARBOXAMIDE 0
                                                  2-[(2-anilino-2-oxoethyl)thio]butanedioic acid 0
                                                  2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-chlorophenyl)acetamide 0
                                                  2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(propylcarbamoylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methylphenyl)acetamide 0
                                                  2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-propan-2-ylphenyl)acetamide 0
                                                  2-[(2R,4aS,12aS)-8-[(2-methoxy-1-oxoethyl)amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(4-fluorophenyl)acetamide 0
                                                  2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide 0
                                                  2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide 0
                                                  2-[(4-cyano-1-methyl-5,6,7,8-tetrahydroisoquinolin-3-yl)thio]-N-(3-ethoxyphenyl)acetamide 0
                                                  2-[(5,6-dithiophen-2-yl-1,2,4-triazin-3-yl)oxy]-N-methyl-N-phenylacetamide 0
                                                  2-[2-[4-[4-(dimethylamino)phenyl]but-3-en-2-ylidene]hydrazinyl]-4-oxo-N-(4-propoxyphenyl)-5,6-dihydro-1,3-thiazine-6-carboxamide 0
                                                  2-[3-(2-furanylmethyl)-2-(4-methoxyphenyl)imino-4-oxo-5-thiazolidinyl]-N-(2-methoxyphenyl)acetamide 0
                                                  2-[3-cyano-4-(methoxymethyl)-6-methyl-2-oxo-1-pyridinyl]-N-(3,5-dimethylphenyl)acetamide 0
                                                  2-[4-[(carbamothioylhydrazinylidene)methyl]-2-methoxyphenoxy]-N-(3,4-dimethylphenyl)acetamide 0
                                                  2-[4-[[[ethylamino(sulfanylidene)methyl]hydrazinylidene]methyl]-2-methoxyphenoxy]-N-(4-methoxyphenyl)acetamide 0
                                                  2-[6-[(2-fluorophenyl)methyl]-5,7-dimethyl-4-oxo-3-pyrrolo[3,4-d]pyridazinyl]-N-(2,3,5,6-tetrafluorophenyl)acetamide 0
                                                  2-[[2-(3,4-dimethylanilino)-2-oxoethyl]thio]acetamide 0
                                                  2-[[4-(dimethylamino)phenyl]methylideneamino]oxy-N-(4-methylphenyl)acetamide 0
                                                  2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide 0
                                                  2-[[5-(2-furanyl)-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)acetamide 0
                                                  2-[[5-[3-(2,4-dichlorophenoxy)propyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-(2-ethyl-6-methylphenyl)acetamide 0
                                                  2-[[6-(2-furanyl)-3-pyridazinyl]thio]-N-(3-methylphenyl)acetamide 0
                                                  2-acetamido-4,5-dimethyl-3-thiophenecarboxylic acid [2-(2-chloro-5-methylsulfonylanilino)-2-oxoethyl] ester 0
                                                  2-amino-N-(4-ethylphenyl)-4-oxo-5,6-dihydro-1,3-thiazine-6-carboxamide 0
                                                  2-butenedioic acid bis[2-(3-chloro-4-methoxyanilino)-2-oxoethyl] ester 0
                                                  2-chloro-N-(2-chloro-5-methylsulfonylphenyl)acetamide 0
                                                  2-chloro-N-ethyl-N-phenylpropanamide 0
                                                  2-chloro-N-heptyl-N-(3-methylphenyl)acetamide 0
                                                  2-cyano-3-(2,5-dimethyl-1H-pyrrol-3-yl)-N-(2-fluorophenyl)-2-propenamide 0
                                                  2-cyano-3-[2,5-dimethyl-1-(3-pyridinyl)-3-pyrrolyl]-N-phenyl-2-propenamide 0
                                                  2-cyano-3-oxo-N-[4-(trifluoromethoxy)phenyl]butanamide 0
                                                  2-cyano-N-(2,4-dimethylphenyl)-3-(3-thiophenyl)-2-propenamide 0
                                                  2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide 0
                                                  2-cyano-N-(2,5-dibromophenyl)-3-oxobutanamide 0
                                                  2-methylpropanethioic acid S-[2-[[[1-(2-ethylbutyl)cyclohexyl]-oxomethyl]amino]phenyl] ester 0
                                                  2-phenylbutanoic acid [2-(3,5-dichloroanilino)-2-oxoethyl] ester 0
                                                  3-(2-chloro-6-fluorophenyl)-N-(2-hydroxy-5-methylphenyl)-4,5-dihydroisoxazole-5-carboxamide 0
                                                  3-(5-cinnamylidene-2,4-dioxo-3-thiazolidinyl)-N-(4-hydroxyphenyl)propanamide 0
                                                  3-(carbamothioylhydrazinylidene)-N-(3,4-dichlorophenyl)butanamide 0
                                                  3-Oxo-N-phenyl-N-(phenylmethyl)butanamide 0
                                                  3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid 0
                                                  3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluoro-4-methylphenyl)propanamide 0
                                                  3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluorophenyl)propanamide 0
                                                  3-[[4-(dimethylamino)phenyl]methylidene]-2-(4-morpholinyl)-N-(3,4,5-trimethoxyphenyl)-1-cyclohexenecarboxamide 0
                                                  3-hydroxy-1-adamantanecarboxylic acid [2-[2-(difluoromethoxy)anilino]-2-oxoethyl] ester 0
                                                  3-methylthiofentanyl + 0
                                                  4-(3-fluoroanilino)-4-oxobutanoic acid 0
                                                  4-(3-methylanilino)-4-oxobutanoic acid 0
                                                  4-(4-acetamidophenyl)-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester 0
                                                  4-(4-chloro-2-methylphenoxy)-N-[3-(methylthio)phenyl]butanamide 0
                                                  4-[3-[2-(4-cyclobutyl-2-thiazolyl)ethenyl]anilino]-2,2-diethyl-4-oxobutanoic acid 0
                                                  4-[5-(4-ethoxyphenyl)-3-isoxazolyl]-N-(3-methoxyphenyl)butanamide 0
                                                  4-[[(2,4-difluoroanilino)-sulfanylidenemethyl]hydrazo]-N-(3,4-dimethylphenyl)-4-oxobutanamide 0
                                                  4-[[4-ethyl-5-[(2-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)-3-oxobutanamide 0
                                                  4-amino-1,2,5-oxadiazole-3-carboxylic acid [2-(2,6-dimethylanilino)-2-oxoethyl] ester 0
                                                  4-anilino-4-oxobutanoic acid (4-tert-butylcyclohexyl) ester 0
                                                  4-chloro-2-methyl-N-[1-[3-[(1-oxo-2-phenoxyethyl)amino]phenyl]ethylideneamino]-3-pyrazolecarboxamide 0
                                                  5-acetylamido-2-chloroaniline 0
                                                  5-amino-1-[2-(2-ethoxyanilino)-2-oxoethyl]-N-(2-furanylmethyl)-4-triazolecarboxamide 0
                                                  5-cyano-6-[[2-(2,3-dimethylanilino)-2-oxoethyl]thio]-4-(2-furanyl)-2-methyl-N-phenyl-1,4-dihydropyridine-3-carboxamide 0
                                                  6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid 0
                                                  6-[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-5-thieno[2,3-b]pyrrolecarboxylic acid methyl ester 0
                                                  6-methyl-N-(2-methylphenyl)-2-oxo-4-phenyl-3,4-dihydro-1H-pyrimidine-5-carboxamide 0
                                                  7-[(3-fluoro-6-oxo-1-cyclohexa-2,4-dienylidene)methylhydrazo]-N-(2-hydroxyphenyl)-7-oxoheptanamide 0
                                                  Actarit 0
                                                  Anilofos 2
                                                  Butenachlor 0
                                                  CID 3191469 0
                                                  CID 3198732 0
                                                  Chloranocryl 0
                                                  Clomeprop 0
                                                  Cypromid 0
                                                  Delachlor 0
                                                  Fosmethilan 0
                                                  LSM-36717 0
                                                  M2 0
                                                  Metsulfovax 0
                                                  Monalide 0
                                                  N'-(2-propoxyphenyl)-2-butenediamide 0
                                                  N'-(cinnamylideneamino)-N-(2-hydroxyphenyl)octanediamide 0
                                                  N'-[(2,3-diethoxyphenyl)methylideneamino]-N-(2-hydroxyphenyl)octanediamide 0
                                                  N'-[[4-(2-hydroxyethoxy)phenyl]methylideneamino]-N-(2-hydroxyphenyl)octanediamide 0
                                                  N(5)-phenyl-L-glutamine 0
                                                  N-(2,4-dichlorophenyl)-2-[[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                                                  N-(2,4-difluorophenyl)-2-[2-methylimino-4-oxo-3-[(4-prop-2-enoxyphenyl)methylideneamino]-5-thiazolidinyl]acetamide 0
                                                  N-(2,4-dimethylphenyl)-N'-(2-furanylmethylideneamino)butanediamide 0
                                                  N-(2,4-dimethylphenyl)-N'-[(5-methyl-2-furanyl)methylideneamino]butanediamide 0
                                                  N-(2,5-difluorophenyl)-2-oxolanecarboxamide 0
                                                  N-(2-chlorophenyl)-2-[[5-[5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                                                  N-(2-ethoxyphenyl)-2-(4-methoxyphenoxy)propanamide 0
                                                  N-(2-ethyl-6-methylphenyl)-2-(4-methyl-1-oxo-2-pyrrolo[1,2-d][1,2,4]triazinyl)acetamide 0
                                                  N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide 0
                                                  N-(2-fluorophenyl)-2-(3-methoxyphenyl)imino-3-methyl-4-oxo-1,3-thiazinane-6-carboxamide 0
                                                  N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide 0
                                                  N-(2-fluorophenyl)-3-phenylpropanamide 0
                                                  N-(2-hydroxyphenyl)-7-[3-(3-methoxy-4-oxo-1-cyclohexa-2,5-dienylidene)prop-1-enylhydrazo]-7-oxoheptanamide 0
                                                  N-(2-hydroxyphenyl)-N'-[(5-nitro-2-thiophenyl)methylideneamino]octanediamide 0
                                                  N-(2-methoxy-5-methylphenyl)-2-[[1-(phenylmethyl)-5-tetrazolyl]thio]acetamide 0
                                                  N-(2-methoxy-5-methylphenyl)-3-(4-methoxyphenyl)sulfonylpropanamide 0
                                                  N-(2-methoxyphenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide 0
                                                  N-(2-methoxyphenyl)-3-[[2-(4-oxo-1-cyclohexa-2,5-dienylidene)-3H-1,3,4-oxadiazol-5-yl]thio]propanamide 0
                                                  N-(2-methoxyphenyl)-N-[(3-oxo-1-benzothiophen-2-ylidene)amino]acetamide 0
                                                  N-(3,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxyiminomethyl]-3-(dimethylamino)-2-propenamide 0
                                                  N-(3,4-dimethylphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide 0
                                                  N-(3,4-dimethylphenyl)-2-[[5-[3-(4-methoxyphenyl)propyl]-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                                                  N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide 0
                                                  N-(3,4-dimethylphenyl)-N'-[(5-nitro-2-furanyl)methylideneamino]butanediamide 0
                                                  N-(3,5-Dichlorophenyl)-2-[4-(2-phenyl-1,3-thiazol-4-yl)pyrimidin-2-yl]sulfanylacetamide 0
                                                  N-(3,5-dichlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide 0
                                                  N-(3,5-dimethylphenyl)-3-(5-nitro-2-thiophenyl)-2-propenamide 0
                                                  N-(3-Benzooxazol-2-yl-4-hydroxy-phenyl)-2-p-tolyloxyacetamide 0
                                                  N-(3-chloro-4-methylphenyl)-2-(2-formylphenoxy)acetamide 0
                                                  N-(3-chloro-4-methylphenyl)-2-[3-(5-methyl-2-tetrazolyl)-1-adamantyl]acetamide 0
                                                  N-(3-chlorophenyl)-2-[4-oxo-2-phenylimino-3-(2-pyridinylmethyl)-5-thiazolidinyl]acetamide 0
                                                  N-(3-chlorophenyl)-2-[[2-(2-pyridinyl)-2,3-dihydro-1,3,4-thiadiazol-5-yl]thio]acetamide 0
                                                  N-(3-chlorophenyl)-2-[[2-(4-chlorophenyl)-6-oxo-1H-1,3,5-triazin-4-yl]thio]acetamide 0
                                                  N-(3-chlorophenyl)-2-[[5-[5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]thio]acetamide 0
                                                  N-(3-chlorophenyl)-2-cyano-3-(3-pyridinyl)-2-propenamide 0
                                                  N-(3-ethylphenyl)-2-phenoxyacetamide 0
                                                  N-(3-fluoro-4-methylphenyl)-1-(2-pyrimidinyl)-3-piperidinecarboxamide 0
                                                  N-(3-hydroxyphenyl)-2-(2,4,5-trichlorophenoxy)acetamide 0
                                                  N-(3-methoxyphenyl)-2-(2-pyridinylthio)acetamide 0
                                                  N-(3-methoxyphenyl)-3-[(4-methylphenyl)thio]propanamide 0
                                                  N-(3-methoxyphenyl)-5-oxo-6,7-dihydro-[1,2,4]triazolo[3,4-b][1,3]thiazine-7-carboxamide 0
                                                  N-(3-methylphenyl)-2-[4-[2-(5-nitro-2,4-dioxo-1H-pyrimidin-6-yl)ethenyl]phenoxy]acetamide 0
                                                  N-(4-acetamidophenyl)-2-(5-methyl-4,5,6,7-tetrahydroindazol-2-yl)acetamide 0
                                                  N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide 0
                                                  N-(4-acetamidophenyl)-2-[5-(1-piperidinylsulfonyl)-2-thiophenyl]acetamide 0
                                                  N-(4-anilinophenyl)-2,2,2-trichloroacetamide 0
                                                  N-(4-anilinophenyl)-2-methylpropanamide 0
                                                  N-(4-anilinophenyl)cyclopropanecarboxamide 0
                                                  N-(4-bromo-2-fluorophenyl)-1-methylsulfonyl-4-piperidinecarboxamide 0
                                                  N-(4-bromo-3-chlorophenyl)-5-oxo-1-propan-2-yl-3-pyrrolidinecarboxamide 0
                                                  N-(4-bromophenyl)-4-[(3-nitro-6-oxo-1-cyclohexa-2,4-dienylidene)methylhydrazo]-4-oxobutanamide 0
                                                  N-(4-chloro-3-methylphenyl)-2-phenoxyacetamide 0
                                                  N-(4-chlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide 0
                                                  N-(4-chlorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide 0
                                                  N-(4-cyclohexylphenyl)-2-(2-hydroxyethylthio)acetamide 0
                                                  N-(4-ethylphenyl)-3-(1-pyrrolyl)propanamide 0
                                                  N-(4-ethylphenyl)-9-bicyclo[6.1.0]non-6-enecarboxamide 0
                                                  N-(4-fluorophenyl)-2-(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)-2-oxoacetamide 0
                                                  N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide 0
                                                  N-(4-fluorophenyl)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-[(4-methoxyphenyl)methyl]acetamide 0
                                                  N-(4-fluorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide 0
                                                  N-(4-fluorophenyl)-N'-hydroxyoctanediamide 0
                                                  N-(4-hydroxyphenyl)-4-[5-[(4-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-3-thiazolidinyl]butanamide 0
                                                  N-(4-hydroxyphenyl)eicosa-5,8,11,14-tetraenamide 0
                                                  N-(4-methoxyphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide 0
                                                  N-(4-methoxyphenyl)-5-oxo-6,7-dihydro-[1,2,4]triazolo[3,4-b][1,3]thiazine-7-carboxamide 0
                                                  N-(4-methoxyphenyl)-9-bicyclo[6.1.0]non-4-enecarboxamide 0
                                                  N-(4-methylphenyl)-2-(3-oxo-5,6-dihydroimidazo[2,1-b]thiazol-2-yl)acetamide 0
                                                  N-(4-methylphenyl)-2-[[(4-methylphenyl)-oxomethyl]hydrazo]-4-oxo-5,6-dihydro-1,3-thiazine-6-carboxamide 0
                                                  N-(4-methylphenyl)-4-oxo-4-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methylhydrazo]butanamide 0
                                                  N-[(2R,4aR,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                                                  N-[(2R,4aR,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                                                  N-[(2R,4aS,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide 0
                                                  N-[(2R,4aS,12aS)-2-[2-(2,6-difluoroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]propanamide 0
                                                  N-[(2R,4aS,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                                                  N-[(2R,4aS,12aS)-2-[2-(4-chloroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methylpropanamide 0
                                                  N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-methylanilino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]cyclobutanecarboxamide 0
                                                  N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(4-propan-2-ylanilino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-isoxazolecarboxamide 0
                                                  N-[(2S,4aR,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                                                  N-[(2S,4aR,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide 0
                                                  N-[(2S,4aS,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide 0
                                                  N-[(2S,4aS,12aS)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide 0
                                                  N-[(4-acetamidophenyl)methylideneamino]-2-cyclohexylacetamide 0
                                                  N-[1-(3-acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide 0
                                                  N-[1-(4-acetamidophenyl)ethylideneamino]cyclopentanecarboxamide 0
                                                  N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide 0
                                                  N-[1-[4-[(2,2,2-trifluoro-1-oxoethyl)amino]phenyl]ethylideneamino]cyclopentanecarboxamide 0
                                                  N-[1-[4-[(2,2,2-trifluoro-1-oxoethyl)amino]phenyl]ethylideneamino]pentanamide 0
                                                  N-[2-[1-(3,5-dimethyl-1-piperidinyl)-1-oxopropan-2-yl]oxyphenyl]acetamide 0
                                                  N-[2-[3-(ethylthio)-5-oxo-2H-1,2,4-triazin-6-yl]phenyl]propanamide 0
                                                  N-[2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenyl]acetamide 0
                                                  N-[3-(2-phenyl-4-thiazolyl)phenyl]propanamide 0
                                                  N-[3-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide 0
                                                  N-[3-[[(3S,3'S,4'R,5'S)-5'-(2-hydroxyethyl)-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-2-oxo-1-spiro[indole-3,2'-oxolane]yl]methyl]phenyl]acetamide 0
                                                  N-[4-(1-azepanyl)phenyl]-2-chloroacetamide 0
                                                  N-[4-(4-morpholinylazo)phenyl]acetamide 0
                                                  N-[4-(benzenesulfonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide 0
                                                  N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide 0
                                                  N-[4-(dimethylamino)phenyl]-3-(5-methyl-2-furanyl)-2-propenamide 0
                                                  N-[4-[(2-furanylmethylamino)-sulfanylidenemethyl]phenyl]acetamide 0
                                                  N-[4-[(8-ethoxy-4,4-dimethyl-5H-dithiolo[3,4-c]quinolin-1-ylidene)amino]phenyl]acetamide 0
                                                  N-[4-[1-(acetylhydrazinylidene)ethyl]phenyl]cyclopropanecarboxamide 0
                                                  N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide 0
                                                  N-[4-[2-(2-oxolanylmethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide 0
                                                  N-[4-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide 0
                                                  N-[4-[2-[(6-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide 0
                                                  N-[4-[2-[2-(1-phenylethylidene)hydrazinyl]-4-thiazolyl]phenyl]acetamide 0
                                                  N-[4-[2-[2-(pyridin-4-ylmethylidene)hydrazinyl]-4-thiazolyl]phenyl]butanamide 0
                                                  N-[4-[2-[5-(6-oxo-1-cyclohexa-2,4-dienylidene)-2H-1,2,4-oxadiazol-3-yl]ethenyl]phenyl]acetamide 0
                                                  N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-phenoxybutanamide 0
                                                  N-[4-[6-amino-5-cyano-4-(3-ethoxy-4-oxo-1-cyclohexa-2,5-dienylidene)-1H-pyridin-2-yl]phenyl]acetamide 0
                                                  N-[4-[[1-(2-furanylmethyl)-2,4,6-trioxo-1,3-diazinan-5-ylidene]methylamino]phenyl]acetamide 0
                                                  N-[4-[[1-[2-(3,4-dimethoxyphenyl)ethyl]-2,4,6-trioxo-1,3-diazinan-5-ylidene]methylamino]phenyl]acetamide 0
                                                  N-[4-[[2-(4-acetamidoanilino)-5-nitro-4-pyrimidinyl]amino]phenyl]acetamide 0
                                                  N-[4-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]phenyl]acetamide 0
                                                  N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-3-methoxybenzamide 0
                                                  N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-5-bromo-2-furancarboxamide 0
                                                  N-[[4-(2,3-dichloroanilino)-4-oxobutan-2-ylidene]amino]-2-methylbenzamide 0
                                                  N-[[4-oxo-4-(2,4,6-trimethylanilino)butan-2-ylidene]amino]carbamic acid tert-butyl ester 0
                                                  N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide 0
                                                  N-cyano-N'-propan-2-ylcarbamimidothioic acid [2-(2-methoxyanilino)-2-oxoethyl] ester 0
                                                  N-phenyl-9-bicyclo[6.1.0]non-6-enecarboxamide 0
                                                  N-phenyl-N'-(pyridin-4-ylmethylideneamino)butanediamide 0
                                                  N-phenylacetamide + 221
                                                  Pentanochlor 0
                                                  Pretilachlor 1
                                                  Prinomide 0
                                                  Pyracarbolid 0
                                                  Sufentanil citrate 0
                                                  Suplatast tosilate 1
                                                  Thenylchlor 0
                                                  U100313 0
                                                  YC 170 0
                                                  acedapsone 0
                                                  acetarsol 0
                                                  arsthinol 0
                                                  benodanil 0
                                                  butacetin 0
                                                  carbamothioic acid S-[2-(2-methoxyanilino)-2-oxoethyl] ester 0
                                                  carboxin 0
                                                  cyclanilide 0
                                                  diampromide 0
                                                  fenfuram 0
                                                  fenoxedil 0
                                                  fentanyl + 17
                                                  glycobiarsol 0
                                                  hydroxyflutamide 24
                                                  iomeglamic acid 0
                                                  linolenic acid anilide 0
                                                  linoleylanilide 0
                                                  methfuroxam 0
                                                  monoacetyldapsone 0
                                                  norfentanyl 0
                                                  o-Chloroacetanilide 0
                                                  oleylanilide 0
                                                  oxycarboxin 0
                                                  p-Chloroacetoacetanilide 0
                                                  p-Lactophenetide 0
                                                  propachlor 3
                                                  propachlor ESA 0
                                                  propachlor OXA 0
                                                  propanil 15
                                                  remifentanil + 3
                                                  salicylanilides + 3
                                                  succisulfone 0
                                                  sufentanil 2
                                                  thienylfentanyl 0
                                                  thioacetazone 0
                                                  thiocyanic acid [4-[(2-chloro-1-oxoethyl)amino]-3,5-dimethylphenyl] ester 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.